col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


460 Results       Page 1

 [1] 
The American Association of Immunologists: The Journal of Immunology
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―05 NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19 Madeline J. Lee, Izumi de los Rios Kobara, Trisha R. Barnard, Xariana Vales Torres, Nicole H. Tobin, Kathie G. Ferbas, et al. (+6)
2 [GO] 2024―Mar―27 Correction: Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Kalipada Pahan
3 [GO] 2024―Mar―22 The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease Suguru Saito, Najmeh Bozorgmehr, Wendy Sligl, Mohammed Osman, Shokrollah Elahi
4 [GO] 2024―Feb―12 Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency Lucy Kundura, Renaud Cezar, Emma Ballongue, Sonia André, Moïse Michel, Clément Mettling, et al. (+12)
5 [GO] 2024―Feb―09 Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort Koji Abe, Joanne C. Beer, Tran Nguyen, Ishara S. Ariyapala, Tyson H. Holmes, Wei Feng, et al. (+5)
6 [GO] 2024―Feb―05 Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report Pushpa Tandon, Natalie D. Abrams, Leela Rani Avula, Danielle M. Carrick, Preethi Chander, Rao L. Divi, et al. (+12)
7 [GO] 2024―Jan―12 Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells Anthony Maino, Axelle Amen, Joël Plumas, Lucie Bouquet, Marina Deschamps, Philippe Saas, et al. (+2)
8 [GO] 2024―Jan―10 Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection Christine M. Bradshaw, Teodora Georgieva, Trevor N. Tankersley, Tama Taylor-Doyle, Larry Johnson, Jennifer L. Uhrlaub, et al. (+2)
9 [GO] 2024―Jan―05 Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models Nisha Rajeswari Dhanushkodi, Swayam Prakash, Afshana Quadiri, Latifa Zayou, Ruchi Srivastava, Amin Mohammed Shaik, et al. (+10)
10 [GO] 2023―Dec―27 Defining Parameters That Modulate Susceptibility and Protection to Respiratory Murine Coronavirus MHV1 Infection Elvia E. Silva, Steven J. Moioffer, Mariah Hassert, Roger R. Berton, Matthew G. Smith, Stephanie van de Wall, et al. (+4)
11 [GO] 2023―Dec―20 Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies Tobias Kammann, Jean-Baptiste Gorin, Tiphaine Parrot, Yu Gao, Andrea Ponzetta, Johanna Emgård, et al. (+17)
12 [GO] 2023―Nov―06 Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies John P. Evans, Shan-Lu Liu
13 [GO] 2023―Oct―02 Infection Dynamics, Pathogenesis, and Immunity to SARS-CoV-2 in Naturally Susceptible Animal Species Mohammed Nooruzzaman, Diego G. Diel
14 [GO] 2023―Sep―27 Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients Yael Rosenberg-Hasson, Tyson H. Holmes, Joann Diray-Arce, Jing Chen, Ryan Kellogg, Michael Snyder, et al. (+5)
15 [GO] 2023―Aug―10 Alteration of metabolite landscape in hypoxia replicates immune cell programs indicative of dysfunctional immunity in severe COVID-19 Elizabeth A Thompson, Laila Stoddart, Wabathi Ngecu, Katherine Cascino, Andrew H. Karaba, Andrea L. Cox
16 [GO] 2023―Aug―10 Localized immune dysregulation is associated with lung injury in severe pediatric COVID-19 Rebecca C Korenberg, Joseph N Bell, Marissa C Bradley, Thomas J Connors
17 [GO] 2023―Aug―10 Long-term metabolomic alterations during post-acute sequelae of COVID-19 Andrea C Wong, Ashwarya Devason, Iboro C Umana, Timothy Cox, Lenka Dohnalová, Nuala J Meyer, et al. (+4)
18 [GO] 2023―Aug―10 Robust T cell responses to the Pfizer/BioNTech vaccine compared to infection and evidence of attenuated CD8+ T cell responses due to COVID-19 Fei Gao, Vamsee Mallajoysula, John D Altman, Taia T Wang, Kari C Nadeau, Scott D Boyd, et al. (+2)
19 [GO] 2023―Aug―10 Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19 Paoline Laurent, Chao Yang, Andre L Rendeiro, Benjamin Nilsson-Payant, Lucia Carrau, Vasuretha Chandar, et al. (+6)
20 [GO] 2023―Aug―10 Spleen tyrosine kinase inhibition restores neutrophil homeostasis in COVID-19 Gustaf Wigerblad, Seth Warner, Marcos Ramos-Benitez, Lela Kardava, Xin Tian, Rui Mao, et al. (+16)
21 [GO] 2023―Aug―10 Paradoxically Increased Inflammation in Immunosuppressed Individuals with COVID-19 James Oscar Moore-Stanley, Sean Blandin Knight, Nawar Bakerly, Sara Kirkham, Thomas Williams, Tracy Hussell
22 [GO] 2023―Aug―10 Dysregulated immune networks define distinct respiratory phenotypes of post-acute sequelae of COVID-19 Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, Jeffrey Sturek, Catherine Bonham, Deborah Murphy, et al. (+7)
23 [GO] 2023―Aug―10 Immune Regulatory Markers in Clinical Cases of COVID-19 Charitha Madiraju, Chandra Shekar Mallarpu, Srinivasa Ikswaja Chelluri, Maneendra Singarapu, Tapaswi Krishna, Lakshmi Kiran Chelluri
24 [GO] 2023―Aug―10 Enhancing immunology based health sciences education for addressing health inequities - in the context of COVID-19 Dianne Sika-Paotonu
25 [GO] 2023―Aug―10 Vaccine Immunology in the context of COVID-19 Dianne Sika-Paotonu
26 [GO] 2023―Aug―10 Viral immunology in the context of COVID-19 Dianne Sika-Paotonu
27 [GO] 2023―Aug―10 Anti-SARS-CoV-2 IgG levels are associated with circulating levels of chemokines CXCL9/CXCL10 and severity disease, but not with RBD-specific B cells 4 months after COVID-19 Romina Andrea Quiroga, Sergio Andrés Sanhueza Novoa, Camilo Daniel Cabrera-Garcia, Bárbara Evelyn Antilef Cáceres, Camila Paz Munoz, Faryd Llerena, et al. (+6)
28 [GO] 2023―Aug―10 Cardiac dysfunction mediators CXCL-9 and chemotaxis of phagocytes characterized patients with long-term pulmonary dysfunction after COVID-19. Sergio Andrés Sanhueza Novoa, Estefania Nova-Lamperti, Camilo Daniel Cabrera-Garcia, Romina Andrea Quiroga, Camila Paz Muñoz Grez, Bárbara Evelyn Antilef Cáceres, Gonzalo Labarca
29 [GO] 2023―Aug―10 Investigating links between persistent symptoms after COVID-19 and longitudinal changes in memory T cell responses to EBV, CMV, HSV-1, and SARS-CoV-2. Jiabao Zhong, Erika L Smith, Christina S McConney, David J Bean, Anna C Belkina, Jennifer E Snyder-Cappione
30 [GO] 2023―Aug―10 Characterization of CD8 +T cells recognizing a dominant epitope of SARS-CoV-2 spike protein in COVID-19 convalescent, vaccinated, and unexposed individuals Ainslee J Zou, Jiangyuan Li, Cecily Choy, Joseph Chen, Humza Hemani, Beverly Baptiste, et al. (+13)
31 [GO] 2023―Aug―10 Understanding of SARS-CoV-2 pathogenicity in COVID-19 cynomolgus macaque model and consideration of its reinfection Emiko Urano, Tomotaka Okamura, Yasuhiro Yasutomi
32 [GO] 2023―Aug―10 Critical COVID-19 disease explained by type I interferon autoantibodies found in patients within the Military Health System. Maria A Leondaridis, Debra Yee, Marana Tso, Elana Shaw, Lindsey B. Rosen, Emily Samuels, et al. (+25)
33 [GO] 2023―Aug―10 Non-fatal outcomes of COVID-19 disease in children with solid organ transplants associates with down-regulation of senescent pathways Kumar Subramanian, Ivy Tesfai, Vinona Muralidaran, Christina Seeley, Lauren Corbert, Nada Yazigi, et al. (+7)
34 [GO] 2023―Aug―10 Epigenetic Memory of COVID-19 in Innate Immune Cells and Their Progen-itors-- Jin Gyu G Cheong
35 [GO] 2023―Aug―10 Role of IgG glycans in severe COVID-19 inflammatory cytokine responses Erin M. Scherer, Jacob D. Sherman, Vinit Karmali, Bhoj Kumar, Trevor W. Simon, Sarah Bechnak, et al. (+15)
36 [GO] 2023―Aug―10 Multi-omic spatial profiling in COVID-19 lung revels temporal evolution of the disease and novel collagen VI biomarker for outcome Matthew R Pugh, Éanna Fennel, Ciara Leahy, Aisling M. Ross, Gary Reynolds, Tracey Perry, et al. (+4)
37 [GO] 2023―Aug―10 Delayed CD4 +T-cell response in older adults is associated with reduced immunogenicity and reactogenicity after COVID-19 mRNA vaccination Norihide Jo, Yu Hidaka, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Masahiko Aoki, et al. (+6)
38 [GO] 2023―Aug―10 Correlates of COVID-19 mRNA vaccine humoral immune responses in men living with HIV-1 Dylan J. Tuttle, Priscila M. S. Castanha, Amro Nasser, Maris S. Wilkins, Deirdre E. Cuff, Prabal Chhibbar, et al. (+5)
39 [GO] 2023―Aug―10 Boosting location of COVID-19 mRNA vaccine regulates the germinal center reaction Wenxia Jiang, Xue Yuan, Scott Renshaw, Wei Luo
40 [GO] 2023―Aug―10 Antibody response of Comirnaty vaccine in different immunocompromised groups during the COVID-19 pandemic Khongorzul Togoo, Burenjargal Batmunkh, Nomin-Erdene Tsogtbayar, Ulziisaikhan Batmunkh, Enkhtuya Selenge, Khuselt-Od Togtokhbaatar, et al. (+4)
41 [GO] 2023―Aug―10 New Complement Dependent Cytotoxicity Assay and its application to COVID-19 patient sera harboring anti-lymphocyte antibodies. Stephanie Calderon, Xiangdong Liu, Andrea Lisco, Anela Kellog, Frances Galindo, Matthew Memoli, et al. (+5)
42 [GO] 2023―Aug―10 Prevalence and complement activation of anti-lymphocyte IgM antibodies in hospitalized COVID-19 patients Ainhoa Perez-Diez, Xiangdong Liu, Stephanie Calderon, Ashlynn Bennett, Andrea Lisco, Anela Kellog, et al. (+7)
43 [GO] 2023―Aug―10 Hospitalized COVID-19 patients exhibit increased numbers of low density neutrophils expressing the transcription factor ARID3a Carol F Webb, James A. Hocker, Malini A. Shankar, John Leland Booth, Lauren A. Sinko, Wenxin Wu, Jordan Metcalf
44 [GO] 2023―Aug―10 Patients who develop insulin resistance 4-months post-COVID-19 exhibited higher NETosis and miR-21-5p expression than COVID-19 patients without metabolic alterations. Camilo Daniel Cabrera-Garcia, Romina Andrea Quiroga, Sergio Andrés Sanhueza Novoa, Bárbara Evelyn Antilef Cáceres, Camila Paz Muñoz Grez, Marco Fraga, et al. (+10)
45 [GO] 2023―Aug―10 Infiltrative monocyte derived adenosine deaminase 2 is associated with COVID-19 related acute respiratory distress syndrome Silpa Tiwari-Heckler, Lisa Vierbaum, Uta Merle, Zhenghui Gordon Jiang
46 [GO] 2023―Aug―10 Inflammatory and immune response signatures associated with COVID-19 severity David S Gibson, Joseph McLaughlin, Darren McDaid, Seodhna Lynch, Maurice OKane, Martin Kelly, et al. (+8)
47 [GO] 2023―Aug―10 Metabolic profiling of COVID-19 severity and mortality: A targeted metabolomics approach Farhan S Cyprian, Asmaa Doudin, Malkan Khatib, Mohamed Elrayess, Hadi Yassine, Abdallah Musa
48 [GO] 2023―Aug―10 Development of broadly protective COVID-19 vaccine against up-to-date variants based on adenovirus type 5/35 vector platform. Chang-Yuil Kang, Soojeong Chang, Kwang-Soo Shin, In Kyung Jung, Hyemin Park, Jonghan Oh, et al. (+3)
49 [GO] 2023―Aug―10 Relatively preserved functional capacity with standard COVID-19 vaccine regimen in People Living with HIV asymptomatic or with mild immunodeficiency Sung-Han Hsiao, Chen-Yiu Hung, Chung-Guei Huang, Tse-Ching Chen, Chia-Shiang Chang, Yu-Lin Huang, et al. (+4)
50 [GO] 2023―Aug―10 Investigating a Role for Eosinophils in the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Maryonne Snow-Smith, Paul J Baker, Andrea C Bohrer, Ehydel Castro, Flor Torres-Juarez, Charles F Anderson, et al. (+4)
51 [GO] 2023―Aug―10 Cross-reactive seasonal coronavirus antibody responses contribute to antibody-mediated effector functions against SARS-CoV-2 in individuals in Kenya. Sinem Ulusan, Shuangyi Bai, Amelie Murrell, Eric Osoro, Jeanette Dawa, Isaac Ngere, et al. (+5)
52 [GO] 2023―Aug―10 Coronavirus spike protein vaccination history affects SARS-CoV-2 receptor-binding domain-specific memory response in a mouse model David Brice, Maureen A McGargill
53 [GO] 2023―Aug―10 Hexavalent coronavirus vaccine elicits both humoral and cellular immune responses in mice Stina Gröhn, Saana Soppela, Alina Iakubovskaia, Arja Pasternack, Vili Lampinen, Olli Ritvos, Minna Hankaniemi
54 [GO] 2023―Aug―10 A case for teaching basic immunology through scientific journalism-lesson taught by a Coronavirus went viral! Nadeem Fazal, Jassam Alsiyaghy, Kirubel Eshetie, Kiara D Wilson, Mohammad Newaz, Hafeez Faridi, et al. (+4)
55 [GO] 2023―Aug―10 Cytotoxic T cells targeting spike glycoprotein are associated with hybrid immunity to SARS-CoV-2 Jolie M Phan, Erik D. Layton, Krystle K.Q. Yu, Melissa S. Aguilar, Inah Golez, Nicholas M. Franko, et al. (+7)
56 [GO] 2023―Aug―10 Adenoviral vector vaccines are effective mucosal booster modalities to elevate systemic and establish mucosal immunity against SARS-CoV-2 Dennis Lapuente, Vera Viherlehto, Jana Fuchs, Jonas Willar, Ana V Antao, Valentina Eberlein, et al. (+18)
57 [GO] 2023―Aug―10 Intramuscular mRNA prime plus intranasal adenoviral vector booster elicit robust respiratory mucosal IgA responses against SARS-CoV-2 Jinyi Tang, Yue Wu, Cong Zeng, Justin J. Taylor, Guizhi Zhu, Drew Weissman, et al. (+2)
58 [GO] 2023―Aug―10 A rationally designed combined intranasal adjuvant drives robust and broad humoral, cellular, and mucosal immune responses to SARS-CoV-2 Pamela T Wong, Sonia Jangra, Jeffrey J Landers, Gabriel Laghlali, Raveen Rathnasinghe, Jessica J O’Konek, et al. (+4)
59 [GO] 2023―Aug―10 Intranasal delivery of adenovirus-vectored vaccine confers protective mucosal immunity against SARS-CoV-2 Hi Eun Jung, Keun Bon Ku, Byeong Hoon Kang, Kyun-Do Kim, Heung Kyu Lee
60 [GO] 2023―Aug―10 Antigen presenting cell targeted T cell DNA vaccine inducing strong and specific cellular responses across multiple T cell epitopes of SARS-COV-2 Gunnstein Norheim, Katarzyna Kuczkowska, Elisabeth Stubsrud, Louise Bjerkan, Marthe Jørgensen, Hannah Husbyn, et al. (+13)
61 [GO] 2023―Aug―10 Studies in humans and mice reveal a critical role for CCR2 in trafficking of pDCs during infection with SARS-CoV-2 Howard H Zhang, Xinping Lu, Davis Garner, Farhat Parween, Satya Singh, Shamik Majumdar, et al. (+13)
62 [GO] 2023―Aug―10 A new mouse model expressing human ACE2, TMPRSS2, and FCGRT for evaluating human antibody responses to SARS-CoV-2 Fernanda Ana-Sosa-Batiz, Shailendra Kumar Verma, Norazizah Shafee, Robyn Miller, Chris Conner, Kathryn M Hastie, et al. (+5)
63 [GO] 2023―Aug―10 Fast Preparation of Peptide Tools to address new emerging Viruses: Case example SARS-CoV-2 Aaron Castro, S Pfeil, Pavlo Holenya, Ulf Reimer, Tobias Knaute, Jonny Zerweck, et al. (+6)
64 [GO] 2023―Aug―10 The Serological Sciences Network (SeroNet); the U.S. government’s effort to boost testing capacity and escalate standardized research on immune responses to SARS-CoV-2 Nancy V Roche, Tom Hickey, Elaine Freund, Patrick Breads, Heidi Hempel, Michelle Berny-Lang, et al. (+5)
65 [GO] 2023―Aug―10 Identifying Epitope Sites on the Receptor Binding Domain (RBD) of SARS-CoV-2 Jiansheng Jiang, Christopher T. Boughter, Javeed Ahmad, Lisa F. Byod, Kannan Natarajan, Martin Meier-Schellersheim, David H Margulies
66 [GO] 2023―Aug―10 Calming the storm: Immunoregulatory receptor NLRX1 and its role in the immune response to SARS-CoV-2 Hannah Ivester, Mackenzie Woolls, Holly A Morrison, Juselyn D Tupik, Christina Chuong, Carla Finkielstein, et al. (+3)
67 [GO] 2023―Aug―10 SARS-CoV-2 Ancestral and Variant of Concern Breakthrough infections boost both cross-reactive cellular and humoral immune responses in mRNA-vaccinated Hamsters. Michael Schotsaert, Juan Garcia-Bernalt Diego, Gagandeep Singh, Sonia Jangra, Adolfo Garcia-Sastre, Manon Laporte, et al. (+10)
68 [GO] 2023―Aug―10 SARS-CoV-2 and SARS-CoV-2 Spike protein S1 subunit Trigger Proinflammatory Response in Macrophages in the Absence of Productive Infection Lindsay Grace Miller, Kim Chiok, Santanu Bose, Tanya A. Miura
69 [GO] 2023―Aug―10 Spike protein vaccine triggers systemic Th2 and Th17 inflammatory responses and pulmonary immunopathology following SARS-CoV-2 breakthrough infection Tianyi Zhang, Nicholas Magazine, Michael C. McGee, Pius Babawale, Sarah Upshaw, Mariano Carossino, et al. (+3)
70 [GO] 2023―Aug―10 The immunodominant SARS-COV-2 CD8 +T cell repertoire is capable of resisting antigenic drift Michael J Malone, Yuwan Guo, Laura Su, Jenny Jiang
71 [GO] 2023―Aug―10 Ackr1-deficient mice are protected from lethal SARS-CoV-2 challenge Shamik Majumdar, Sergio M Pontejo, Joseph Weaver, Philip M Murphy
72 [GO] 2023―Aug―10 SARS-CoV-2 Delta requires human ACE2 but not human TMPRSS2 to infect mice and elicits greater lung injury and adaptive immune response than Omicron in human ACE2 knock-in mice Shailendra Kumar Verma, Fernanda Ana-Sosa-Batiz, Norazizah Shafee, Julia Timis, Erin Maule, Robyn Miller, et al. (+7)
73 [GO] 2023―Aug―10 Age-associated variations in anti-spike antibody responses in mild SARS-CoV-2 disease. Emily Parsons, Stephanie Richard, Eric Laing, Anthony Fries, Jeffrey Livezey, Milissa Jones, et al. (+21)
74 [GO] 2023―Aug―10 The extracellular tail of IFITM3 promotes SARS-CoV-2 entry into cells and is diversifying in primates Alex A Compton, Tiansheng Li, Guoli Shi, Kin Kui Lai, Nelly Mak, Abigail Jolley, et al. (+3)
75 [GO] 2023―Aug―10 SARS-CoV-2 Envelope Protein Tolerizes Macrophage Response to Secondary Inflammatory Stimuli Stephen H Pierce, Rebecca Mclennan, Santosh Khanal, Heather Menden, Vankatesh Sampath, Todd Bradley
76 [GO] 2023―Aug―10 Peering into the future of SARS-CoV-2 evolution using a computational model of the SARS-CoV-2 serum antibody repertoire Liel Cohen-Lavi, Eilay Koren, Yan Yegorov, Sinai Sacharen, Anat Burkovitz, Tomer Hertz
77 [GO] 2023―Aug―10 mRNA vaccination induces persistent pharyngeal mucosal B cell responses to SARS-CoV-2 in children Qin Xu, Pamela Mudd, Hengameh Behzadpour, Daniel Newman, Lorenza Bellusci, Gabrielle Grubbs, et al. (+9)
78 [GO] 2023―Aug―10 Unraveling the cell death induced by SARS-CoV-2 in lung epithelial cells Kaixin Liang, Katherine Camille Barnett, Yuying Xie, Thomas Oguin, Gregory D Sempowski, Yu Leo Lei, Jenny P Ting
79 [GO] 2023―Aug―10 Dysregulated myeloid cell activity is associated with fatal disease in SARS-CoV-2 infected aged mice Debarati Chanda, Roshan Ghimire, Rudragouda Channappanavar, Matthias Mack
80 [GO] 2023―Aug―10 Immunoregulatory Roles of TGF-β and IL-4 during Mouse-adapted SARS-CoV-2 Infection Solomon Taye Sima, Lucinda Puebla-Clark, Maria Gonzalez-Orozco, Thomas R Shelite, Hannah G Federman, Matthew B Huante, et al. (+8)
81 [GO] 2023―Aug―10 Amniotic fluid derived extracellular vesicles as novel anti-inflammatory therapeutics against SARS-CoV-2 infection Debarati Chanda, Michael A. Bellio, Tania del Rivero, Maria Ines Mitrani, Rudragouda Channappanavar
82 [GO] 2023―Aug―10 IL-33 promotes inflammatory responses and exacerbates lung pathology in a mouse model of SARS-CoV-2 infection Yuejin Liang, Hui Wang, Yashoda Madaiah Hosakote, Casey Gonzales, Xuping Xie, Pei-Yong Shi, et al. (+3)
83 [GO] 2023―Aug―10 Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection. John T Bates, Seth T. Lirette, Andrew P. Farmer, Michael A. Bierdeman, Kristina B. Seyfarth, Denise D. Montgomery, et al. (+3)
84 [GO] 2023―Aug―10 Bi-directional epithelial-immune communication amplifies inflammasome activation and IL-6 release during SARS-CoV-2 infection Katherine Camille Barnett, Yuying Xie, Takanori Asakura, Dingka Song, Kaixin Liang, Sharon A. Taft-Benz, et al. (+12)
85 [GO] 2023―Aug―10 High Mobility Group Box 1: A Predictive Biomarker of Aberrant Humoral Responses Implicated in Post-Acute Sequelae of SARS-CoV-2 Infection Noelle C Rubas, Rafael Aniu Peres-David, Braden P Kunihiro, Krit Phankitnirundorn, Trevor McCraken, Lesley Umeda, et al. (+2)
86 [GO] 2023―Aug―10 Interferon-lambda accelerates viral clearance and regulates CD8 +T cells immunity in a murine model of SARS-CoV-2 infection Abigail Solstad, Adam D Kenney, Najmus Sahar Mahfooz, Ashley Zani, Jeffrey Kawahara, Richard T Robinson, et al. (+3)
87 [GO] 2023―Aug―10 Inhibited MHC Class I and MHC Class II antigen processing and presentation upon Sars-CoV-2 infection Padma Pandurang Nanaware, John Cruz, Muneeruddin Khaja, Scott A Shaffer, Lawrence Stern
88 [GO] 2023―Aug―10 Phenotypical and Functional Characterization of Unswitched Memory B cells verses Switched during SARS-CoV-2 Infection Moriah J Castleman, Adriana Luna Santos, Kelsey Lesteberg, James Maloney, William Janssen, Kara Mould, et al. (+3)
89 [GO] 2023―Aug―10 Role of HMGB1 in the activation of innate immune responses during SARS-CoV-2 infection Yashoda Madaiah Hosakote, Kempaiah Rayavara, Yuejin Liang, Corri B Levine, Scott C Weaver, Bill T Ameredes, et al. (+4)
90 [GO] 2023―Aug―10 Persistent CD4 T cell functional deficits in individuals recovered from prolonged symptomatic SARS-CoV-2 infection Susan Kovats, Christina Lawrence, Sean Turner, Nathan Pezant, Nancy Redinger, Carla Guthridge, et al. (+4)
91 [GO] 2023―Aug―10 SARS-CoV-2 infection and Spike protein exposure alter iPSC-derived human brain organoid homeostasis. Gioia Cappelletti, Lorenzo Brambilla, Valentina Melzi, Mafalda Rizzuti, Monica Nizzardo, Daria Trabattoni, et al. (+3)
92 [GO] 2023―Aug―10 Multiplex assays to determine correlation of binding and neutralizing antibodies following SARS-CoV-2 infection and vaccination Neeraja Venkateswaran, Jawad Sarwar, William Max Nelson, Kodumudi S Venkateswaran
93 [GO] 2023―Aug―10 Longitudinal analysis of the LA-SPARTA cohort of high-risk individuals after SARS-CoV-2 infection and vaccination Meagan M Jenkins, Donna Phan Tran, Evelyn A Flores, Deborah Kupferwasser, Harry Pickering, Ying Zheng, et al. (+6)
94 [GO] 2023―Aug―10 IL-13 protects epithelial cells from SARS-CoV-2 infection by inhibiting early ACE2-mediated events Vadim I Pivniouk, Oksana Pivniouk, Jennifer Uhrlaub, Allyson Molzahn, Hiroki Kimura, Julie Ledford, et al. (+3)
95 [GO] 2023―Aug―10 Neutrophilia and neutrophil-derived extracellular traps as innate immune markers of SARS-CoV-2 infection in a feline animal model Sachithra J Gunasekara, Breya Ludwig, Shannon Cowan, Miruthula Tamil Selvan, Jerry Ritchey, Craig Miller, Jennifer Rudd
96 [GO] 2023―Aug―10 Longitudinal analysis reveals age-dependent immune responses to SARS-CoV-2 infection in a mouse model Wei Qian, Xiaoqin Wei, Barbara J Mann, Jie Sun
97 [GO] 2023―Aug―10 IL-10 promotes tissue-resident memory T cells (T RM) in the respiratory tract during SARS-CoV-2 infection in rhesus macaques Christine Nelson, Taylor Foreman, Sivaranjani Namasivayam, Keith Kauffman, Felipe Gomez, Shunsuke Sakai, et al. (+4)
98 [GO] 2023―Aug―10 Vaccination prior to SARS-CoV-2 infection reduces autoreactive antibody induction Chun-Yang Lin, Ashley Castellaw, David Brice, Stacey Schultz-Cherry, Paul Thomas, Josh Wolf, Maureen McGargill
99 [GO] 2023―Aug―10 Autoantibodies produced by SARS-CoV-2 infection trigger damage to the lacrimal and salivary glands and lead to the development of Sjögren’s Disease Yiran Shen, Alexandria Voigt, Laura Goranova, Mehdi Abed, David Kleiner, Jose Maldonado, et al. (+8)
100 [GO] 2023―Aug―10 Improved control of SARS-CoV-2 infection with nucleocapsid-specific antibodies Pablo A Penaloza-MacMaster, Tanushree Dangi, Sarah Sanchez, Jacob Class, Michelle Richner, Lavanya Visvabharathy, et al. (+6)
101 [GO] 2023―Aug―10 The emergence of SARS-CoV-2 lineages and associated antibody responses among asymptomatic individuals in a large university community Marlena Rae Merling, Najmus Mahfooz, Richard T Robinson
102 [GO] 2023―Aug―10 Baseline HMGB-1 Concentrations Are Predictive of Neutralization Efficacy after SARS-CoV-2 mRNA Vaccination Lesley K Umeda, Braden P Kunihiro, Noelle C Rubas, Riley K Wells, Krit Phankitnirundorn, Rafael Aniu Peres-David, Alika K Maunakea
103 [GO] 2023―Aug―10 Anamnestic expansion of Omicron-reactive CD8 +T cells after booster SARS-CoV-2 mRNA vaccination across different immunocompromised states Thomas R Müller, Takuya Sekine, Darya Trubach, Julia Niessl, Anna Olofsson, Yu Gao, et al. (+11)
104 [GO] 2023―Aug―10 CD8 +T-cell memory induced by SARS-CoV-2 mRNA vaccination is maintained by clonal replenishment Hiroyasu Aoki, Masahiro Kitabatake, Haruka Abe, Shigeyuki Shichino, Atsushi Hara, Noriko Ouji-Sageshima, et al. (+3)
105 [GO] 2023―Aug―10 Design and Preclinical Evaluation of a Universal SARS-CoV-2 mRNA Vaccine Laura Katherine Langston, Renhuan Xu, Huabin Zhu, Jane Qin, Ju Jeon, Jiangsheng Xu, Stephanie Mou
106 [GO] 2023―Aug―10 Altered antibody profiles after receipt of third dose SARS-CoV-2 mRNA vaccines in solid organ transplant recipients Jenny MinChen Lee, Janna R. Shapiro, John S. Lee, Ioannis Sitaris, Stephanie R. Peralta, Maggie Li, et al. (+7)
107 [GO] 2023―Aug―10 Investigating SARS-CoV-2 ORF3a binding to human TRAF2 and TRAF3 Brianna M. Busscher, Henock Befekadu, Zhonghua Liu, Chuanping Wang, Tsan Sam Xiao
108 [GO] 2023―Aug―10 Correlates of immunity in SARS-CoV-2 post-vaccine infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study Emilie Goguet, Carol Weiss, Cara Olsen, John Powers, Si’Ana Coggins, David Tribble, et al. (+29)
109 [GO] 2023―Aug―10 SARS-CoV-2 RBD-specific atypical memory B cells exhibit effector memory-like features in multi-dose mRNA vaccination Jeongsoo Lee, Sung-Han Kim, Eui-Cheol Shin, Su-Hyung Park
110 [GO] 2023―Aug―10 Modeling the SARS-CoV-2 receptor ACE2 indicates that protein-bound Zn affects distant protein stability and interactions Peter R Fatouros, Urmi Roy, Shantanu Sur
111 [GO] 2023―Aug―10 SARS-CoV-2 seroreversion is associated with a decrease in T cell functionality in children Megan A Files, Leanne Kehoe, Amanda Adler, Janet Englund, Chetan Seshadri
112 [GO] 2023―Aug―10 Clonal dynamics of SARS-CoV-2 specific CD4 T cells in lymph nodes after vaccination laurent Bartolo, Yi-Gen Pan, Sumbul Afroz, Laura Su
113 [GO] 2023―Aug―10 Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge Gina Cusimano, Ebony N. Gary, Nicholas J Tursi, Bryce M Warner, Jennifer Connors, Elizabeth M Parzych, et al. (+17)
114 [GO] 2023―Aug―10 Oral tablet vaccination against SARS-CoV-2 spike boosts cross-reactive serum and mucosal neutralizing antibodies following mRNA vaccination: a phase 2 clinical trial susan johnson, Clara B Jegede, Samanta Gutierrez, Susan Greco, James Cummings, Keith A Gottlieb, Sean N Tucker
115 [GO] 2023―Aug―10 Role of germinal center response in the antibody responses against SARS-CoV-2 spike protein Jumana A T Khalil, Kosuke Miyauchi, Yuichiro Yamamoto, Kohji Noguchi, Kazuo Takayama, Masato Kubo
116 [GO] 2023―Aug―10 Roles of glycosylation and redox states on SARS-CoV-2 spike protein actions Jennyfer Bejoy, Tinatin I. Brelidze, Yuichiro J. Suzuki
117 [GO] 2023―Aug―10 Genetic immunization with self-assembling SARS-CoV-2 Spike-HBsAg nanoparticles Jonah S Merriam, Catherine Liu, Lingshu Wang, Wei Shi, Eun-Sung Yang, Yi Zhang, et al. (+14)
118 [GO] 2023―Aug―10 Fc properties of SARS-CoV-2 spike-specific antibodies elicited by vaccines and infection Catarina E Hioe, Jeromine Klingler, Juan Bandres, Rozita Emami-Gorizi, Fatima Amanat, Shreya Kowdle, et al. (+5)
119 [GO] 2023―Aug―10 Development and Characterization of a novel humanized ACE2 mouse model to study the pathogenesis of viral lung infection by variable SARS-CoV-2 strains Chang-Yong Choi, Jason Villano, Andy Pekosz, Hongpeng Jia
120 [GO] 2023―Aug―10 Prior infection exposure alters the immune response at homeostasis and following SARS-CoV-2 vaccination and experimental infection in laboratory mice. Victoria Kate Baxter, Audrey C. Knight, Jacob A. Dillard, Elizabeth J. Anderson, Katia D. Pressey, Brea K. Hampton, et al. (+7)
121 [GO] 2023―Aug―10 Passive antibody transfer from pregnant women to their fetus are maximized after SARS-CoV-2 vaccination irrespective of prior infection Cody Lauritsen, Ivy Trinh, Srushti Desai, Erin Clancey, Amelie Murrell, Saraswatie Rambaran, et al. (+14)
122 [GO] 2023―Aug―10 Intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate confers potent mucosal and systemic immunity and protection Awadalkareem Adam, Birte K Kalveram, Jing Zou, Leslie Rodriguez, Ankita Singh, John Yun-Chung Chen, et al. (+3)
123 [GO] 2023―Aug―10 A SARS-CoV-2 vaccine designed for manufacturability results in unexpected potency and non-waning humoral response. Stephen Anderson, Elliot Campbell, Julie Dobkin, Louis Osorio, Afsal Kolloli, Santhamani Ramasamy, et al. (+4)
124 [GO] 2023―Aug―10 Insufficient epitope specific T cell clones is responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in the elderly Chanchan Xiao, Guobing Chen
125 [GO] 2023―Aug―10 SARS-CoV-2 Vaccine-Elicited Antibody Responses in Breastmilk Caitlin Williams, Mackensie Gross, Savannah Herbek, Sallie Permar, Yawei Yang
126 [GO] 2023―Aug―10 Omicron Breakthrough Infection Elicits Superior Humoral and Mucosal Immunity to SARS-CoV-2 Variants than Booster Doses Sabryna Nantel, Salma Sheikh-Mohamed, Gary Chao, Queenie Hu, Alexandra Kurtesi, Heidi Wood, et al. (+9)
127 [GO] 2023―Aug―10 Mucosal chemokine adjuvant supports heterologous protection against Delta and Omicron VOCs in the context of a SARS-CoV-2 wild-type DNA vaccine Ebony Nicole Gary, Nicholas J Tursi, Bryce M Warner, Elizabeth M Parzych, Ali R Ali, Drew Frase, et al. (+9)
128 [GO] 2023―Aug―10 Differential role of TLR7 signaling in SARS-CoV-2-induced antiviral and inflammatory responses Roshan Ghimire, Titus Patton, Rakshya Shrestha, Debarati Chanda, Sunil More, Rudragouda Channappanavar
129 [GO] 2023―Aug―10 Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc Shie-Liang Hsieh
130 [GO] 2023―Aug―10 Pre-existing SARS-CoV-2-reactive CD4 +T cells are established and highly functional in early childhood Anna Olofsson, Marion Humbert, Julia Niessl, Emma Hodcroft, Yu Gao, Ebba Sohlberg, et al. (+7)
131 [GO] 2023―Aug―10 Design and Characterization of Bivalent Molecules Against SARS-CoV2 Javeed dhobi Ahmad, Jiansheng Jiang, Richard W. Perks, Bernard Lafont, Tracey Burdette, Johnson Reed, et al. (+4)
132 [GO] 2023―Aug―10 SARS-CoV2 Decreases Human Beta-Defensin-1 and FoxI1 in the Oral Cavity Without Affecting CFTR Lisa K Ryan, Weston J. Barney, Paige K. Tierney, Jumin S. Kim, Tanya O. Robinson, Neha S. Dhaliwal, et al. (+2)
133 [GO] 2023―Aug―10 NF-κB signaling promotes SARS-CoV2 infection in human lung epithelial cells Zienab Etwebi, Kasirajan Ayyanathan, Jesse Miller, Brinda Kamalia, Minghua Li, Jae Seung Lee, et al. (+8)
134 [GO] 2023―Aug―10 Pandemic preparedness: Addition of TLR agonists CpG+MPLA to emulsified H5 confers protection against H5N1 challenge after a single dose. Jenny E Davies, Michael Hwang, Emmanuel Dollinger, Jiin Felgner, Aarti Jain, Qing Nie, et al. (+3)
135 [GO] 2023―Aug―10 Immune system perturbations in patients with severe long COVID Lucie Rodriguez, Ziyang Tan, Tadepally Lakshmikanth, Jun Wang, Hugo Barcenilla, Laura Gonzalez, et al. (+8)
136 [GO] 2023―Aug―09 Intestinal IL-1β Plays a Role in Protecting against SARS-CoV-2 Infection Jöran Lücke, Fabian Heinrich, Jakob Malsy, Nicholas Meins, Josa Schnell, Marius Böttcher, et al. (+21)
137 [GO] 2023―Jul―26 Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2 Hong Yu, Liam J. Worrall, Thorsten Berger, Martin Petric, Bryan H. Lin, Marija Vuckovic, et al. (+25)
138 [GO] 2023―Jul―03 Considerations for Choosing T Cell Assays during a Pandemic Jaclyn C. Law, Tania H. Watts
139 [GO] 2023―Jun―16 Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases Michelle W. Cheung, Roya M. Dayam, Janna R. Shapiro, Jaclyn C. Law, Gary Y. C. Chao, Daniel Pereira, et al. (+20)
140 [GO] 2023―Jun―02 SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor Nicole O. Ponde, Karsen E. Shoger, Mst Shamima Khatun, Mrinal K. Sarkar, Ipsita Dey, Tiffany C. Taylor, et al. (+6)
141 [GO] 2023―May―05 Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19 Ramesh K. Paidi, Malabendu Jana, Sumita Raha, Rama K. Mishra, Brian Jeong, Monica Sheinin, Kalipada Pahan
142 [GO] 2023―Apr―26 Recombinant Bacillus Calmette-Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge Fábio Mambelli, Fábio V. Marinho, Juvana M. Andrade, Ana C. V. S. C. de Araujo, Rodrigo P. F. Abuna, Victor M. R. Fabri, et al. (+11)
143 [GO] 2023―Apr―12 Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19 Heejin Nam, June-Young Koh, Jae Hyung Jung, Hyeongseok Jeong, Hye Won Jeong, Shinhye Cheon, et al. (+3)
144 [GO] 2023―Mar―24 Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2 Jolie M. Phan, Erik D. Layton, Krystle K. Q. Yu, Melissa S. Aguilar, Inah Golez, Nicholas M. Franko, et al. (+7)
145 [GO] 2023―Mar―07 Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology Mohamed M. Shamseldin, Adam Kenney, Ashley Zani, John P. Evans, Cong Zeng, Kaitlin A. Read, et al. (+14)
146 [GO] 2023―Feb―13 Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination Michael Quinn, Luis Parra-Rodriguez, Wafaa B. Alsoussi, Chapelle Ayres, Michael K. Klebert, Chang Liu, et al. (+11)
147 [GO] 2023―Feb―07 SARS-CoV-2 spike binding peptides: A potential therapeutic approach for COVID-19 Santhamani Ramasamy, Siddiqui Zain, Abhishek Roy, Ranjeet Kumar, Afsal Kolloli, Theresa Li-Yun Chang, et al. (+2)
148 [GO] 2023―Feb―07 Profound phenotype alteration and delayed regeneration of circulating antigen presenting cells in COVID-19 Elena Winheim, Linus Rinke, Konstantin Lutz, Anna Reischer, Maximilian Münchhoff, Johannes Hellmuth, et al. (+3)
149 [GO] 2023―Feb―07 Phosphatidylserine Receptor Enhancement of SARS-CoV-2 Entry: AXL as a Therapeutic Target for COVID-19 Dana Bohan, Hanora Van Ert, Kai Rogers, Natalie Ruggio, Roberth Anthony Rojas Chávez, Tomasz Stokowy, et al. (+6)
150 [GO] 2023―Feb―07 Designing a bispecific antibody targeting IL-6Rα and NKG2A receptors via in silico affinity maturation as a strategy to combat severe COVID-19 Manusmriti Agarwal, Samvedna Saini, Spandan Kaushik, Aakanksha Prasad, Yatender Kumar
151 [GO] 2023―Feb―07 Development of a gp96-Ig vaccine for COVID-19 Natasa Strbo, Eva Fisher, Laura Padula, Katelyn Elizabeth O’Neill
152 [GO] 2023―Feb―07 TVGN-489: A novel approach for the production of SARS-CoV-2-specific cytotoxic T lymphocytes to treat COVID-19 Neal Flomenberg, John Lyle Wagner, Yuri Sykulev, Nadezhda Anikeyeva, Yanping Huang, Michael Sun, et al. (+12)
153 [GO] 2023―Feb―07 Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 Lauren Barbara Rodda, Jason Netland, Laila Shehata, Kurt B. Pruner, Peter A. Morwaski, Christopher D. Thouvenel, et al. (+18)
154 [GO] 2023―Feb―07 Lupus-like extrafollicular B cell responses and autoreactivity are hallmarks of severe COVID-19 Matthew C Woodruff, Richard P Ramonell, F. Eun-Hyung Lee, Ignacio Sanz
155 [GO] 2023―Feb―07 Virtual graduate immunology and immunotherapy education during COVID-19 Rosalie Sterner, Karen E Hedin
156 [GO] 2023―Feb―07 Diverse Functional Autoantibodies that Underlie Immune Perturbations in COVID-19 Tianyang Mao, Eric Y. Wang, Jon Klein, Yile Dai, John D. Huck, Feimei Liu, et al. (+25)
157 [GO] 2023―Feb―07 A single center, double blind, randomized, placebo controlled trial of anakinra in adult patients with features of Cytokine Storm Syndrome in COVID-19 Randy Q Cron, Lesley E Jackson, Nitasha Khullar, Christopher A Chapleau, W Winn Chatham
158 [GO] 2023―Feb―07 COVID-19 affected “face to face” interaction with the professors. Lessons learned from traditional learning. Sandra R Olk, Ryan Stempek, Sahira Renteria, Nadeem Fazal
159 [GO] 2023―Feb―07 DOCK8 mutations in COVID-19 and MIS-C Cytokine Storm Syndrome Randy Q Cron, Mingce Zhang, Remy R Cron, Devin Absher, John M Bridges, Amanda Schnell, et al. (+6)
160 [GO] 2023―Feb―07 Optimizing immunoassay-based selection of donors for COVID-19 convalescent plasma Hanora A Van Ert, Kai Rogers, Dana Bohan, Chanze Han, Spencer Dempewolf, Kristina Sevcik, et al. (+9)
161 [GO] 2023―Feb―07 HLA allele frequencies and susceptibility analysis in 94 Florida residents with COVID-19 disease Yiran Shen, Cuong Q Nguyen, David A Ostrov
162 [GO] 2023―Feb―07 Distinct peripheral inflammatory profiles distinguish COVID-19 from influenza infection, with limited contributions from cytokine storm Jeremy Chase Crawford, Philip A. Mudd, Jackson S. Turner, Aisha Souquette, Daniel Reynolds, Diane Bender, et al. (+13)
163 [GO] 2023―Feb―07 Patient-reported comorbidity affects symptom duration in non-hospitalized patients with mild to moderate COVID-19 in a clinical study John P Haran, Yan Zheng, Norma Alonzo-Palma, Mark Wingertzahn
164 [GO] 2023―Feb―07 Frequency and phenotype of SARS-CoV-2-specific CD8+ T cells in healthy and convalescent COVID-19 individuals Cecily Choy, Jian Lu, Jiangyuan Li, Christopher Dunn, Tonya Wallace, Cuong Nguyen, et al. (+4)
165 [GO] 2023―Feb―07 Immune profiling of COVID-19 infection in pediatric solid organ transplantation Udeme D Ekong, Saikat Paul, Scott Royal, Joeffrey Chahine, Nada Yazigi, Stuart Kaufman, et al. (+4)
166 [GO] 2023―Feb―07 Aberrant CD39 levels and regulation mark COVID-19 late stage Maria Serena Longhi, Na Wang, Ahmadreza Kalbasi, Marta Vuerich, Zachary J. Manickas-Hill, Jonathan Hecht, et al. (+2)
167 [GO] 2023―Feb―07 Type 2 Diabetes Increased the Risk of Hyposmia in COVID-19 Mild Pneumonia Patients by Suppressing Nasal Immunity Jun Zhang, Ye Tao, Zhaohui Xu, Yehai Liu
168 [GO] 2023―Feb―07 Development of a quantitative COVID-19 Multiplex Assay and its use for serological surveillance in a low SARS-CoV-2 incidence community Cassandra M Guarino, Elisabeth Larson, Susanna Babasyan, Alicia Rollins, Lok Joshi, Melissa Laverack, et al. (+4)
169 [GO] 2023―Feb―07 Titers, prevalence and duration of SARS-CoV-2 antibodies in two waves of a local COVID-19 outbreak Jodi F Hedges, Macy A. Thomspon, Deann T. Snyder, Amanda Robison, Matthew P. Taylor, Mark A Jutila
170 [GO] 2023―Feb―07 Disadvantaged students at minority serving institutions became disproportionally affected by the current COVID-19 pandemic. Sahira Renteria, Ryan Stempek, Sandra R Olk, Nadeem Fazal
171 [GO] 2023―Feb―07 Obesity effects serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients Bonnie Blomberg, Lisa Reidy, Maria Romero, Alain Diaz, Carolyn Cray, Kristin Kahl, Daniela Frasca
172 [GO] 2023―Feb―07 SARS-CoV-2 mediated monocytes dysregulation may contribute to increase risk of cardiovascular risk in severe COVID-19 patients. Manuja Gayashan Bandara Gunasena, Yasasvi Wijewantha, Emily Bowman, Janelle Gabriel, Amrendra Kumar, Aaren Kettelhut, et al. (+9)
173 [GO] 2023―Feb―07 Diminished monocyte response in severe COVID-19 patients. Meredith E Davis-Gardner, Venkata Edara, Lilin Lai, Fengzhi Jin, Katharine Floyd, Lindsay Nyhoff, et al. (+12)
174 [GO] 2023―Feb―07 Abnormal C5 production and activation contributes to the mortality of COVID-19 patients Zhou Fang, Xiang Li, Tzu Hsuan Cheng, Shreya Desikan, Samrat Worah, Robert Foronjy, et al. (+11)
175 [GO] 2023―Feb―07 SARS-CoV-2 plasma viral load polarizes the systemic myeloid cell compartment towards an immunosuppressive/regulatory phenotype in severe COVID-19 patients Amelia Chiara Trombetta, Guilherme Borlido de Carvalho Farias, Ana Godinho-Santos, André MC Gomes, Pedro Rosmaninho, Carolina M. Conceição, et al. (+6)
176 [GO] 2023―Feb―07 Unique immune signatures predict potential cardiometabolic risk in severe COVID-19 patients and COVID-19 recovered individuals Namal Liyanage, Manuja Gunasena, Yasasvi Wijewantha, Emily Bowman, Janelle Gabriel, Amrendra Kumar, et al. (+9)
177 [GO] 2023―Feb―07 Flow cytometry analysis of immune response to COVID-19 vaccine candidates using an in vitro stimulation model Xiaoshan Shi, Scott J Bornheimer, Suraj Saksena, Stephanie Widmann, Aaron Tyznik
178 [GO] 2023―Feb―07 Combinations of alum and synthetic toll-like receptor agonists as adjuvants for CoVID-19 vaccines Clara J Davison, Haley A Partlow, Stephanie K Lathrop, Karthik Siram, Walid Abdelwahab, David J Burkhart, Jay Evans
179 [GO] 2023―Feb―07 Host responses to feline coronavirus are significantly different in primary macrophages compared to CRFK cells. Yvonne Drechsler, Elton J.R. Vasconcelos, Lisa M Griggs, Pedro P.P.V. Diniz
180 [GO] 2023―Feb―07 Coronavirus induces diabetic macrophage-mediated inflammation via IFN-beta regulation of SETDB2 William James Melvin, Christopher Audu, Amrita Joshi, Frank Davis, Emily Barrett, Kevin Mangum, et al. (+3)
181 [GO] 2023―Feb―07 Characterization of cross-reactive immunity following coronavirus vaccination or natural infection Tanushree Dangi, Nicole M Palacio, Sarah Sanchez, Pablo Penaloza-MacMaster
182 [GO] 2023―Feb―07 Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses John Altin, Jason T Ladner, Denis Kainov, Sergey Shiryaev, Sierra Henson, Annalee Boyle, et al. (+2)
183 [GO] 2023―Feb―07 High levels of endemic coronaviruses reactive CD4+ T cells in SARS-CoV-2 seronegative health care workers Ricardo Filipe da Silva Antunes, Suresh Pallikkuth, Erin Williams, Esther Dawen Yu, Jose Mateus, Lorenzo Quiambao, et al. (+16)
184 [GO] 2023―Feb―07 Type I Interferon Shapes Humoral Immunity to SARS-CoV-2 Benjamin Goldman-Israelow, Tianyang Mao, Eric Song, Peiwen Lu, Patrick Wong, Carolina Lucas, et al. (+2)
185 [GO] 2023―Feb―07 IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10 Mary K Young, Christine Kornmeier, Rebecca Carpenter, Nick Natale, Jennifer Sasson, Michael Solga, et al. (+4)
186 [GO] 2023―Feb―07 Determining Adenosine Deaminase 1 (ADA-1) Impact on Immune Memory and Durability as a Molecular Adjuvant in a SARS-CoV-2 DNA Vaccine Formulation. Gina Cusimano, Ebony N. Gary, Matt Bell, Jennifer R Connors, Nicholas J. Tursi, Shiyu Zhang, et al. (+10)
187 [GO] 2023―Feb―07 Novel Mechanisms of Innate Immune System Regulation Following SARS-CoV-2 Exposure Irving C Allen, Hannah Ivester, Holly Morrison, Carla Finkielstein, Jonathan Auguste, Nisha Duggal, et al. (+4)
188 [GO] 2023―Feb―07 Development and Characterization of Potential Neutralizaing Antibodies to SARS-CoV-2 from Phage Display Human Antibody Library System In Ho Park, Sang Pil Lee, Sunha Yoon, Ji-Young Shin, Jooyeon Oh, Hoojung Lee, et al. (+3)
189 [GO] 2023―Feb―07 Natural infection with SARS-CoV-2 generates durable Spike S1 Receptor-Binding-Domain-specific memory B cell and neutralizing antibody responses. Pankaj Kumar Mishra, Natalie Bruiners, Rahul Ukey, Pratik Datta, Alberta Onyuka, Deborah Handler, et al. (+5)
190 [GO] 2023―Feb―07 BCG-derived peptides induce T cell cross-reactivity to Sars-CoV-2 homologues P J Eggenhuizen, Boaz H Ng, Janet Chang, Ashleigh L Fell, Joshua D Ooi
191 [GO] 2023―Feb―07 Frozen CyTOF panel enables robust and consistent longitudinal assessment of the SARS-CoV-2 immune landscape Carolina Acosta-Vega, David Skibinski, Anna Kus, Cate Speak, Alice Long, Uma Malhotra, et al. (+2)
192 [GO] 2023―Feb―07 An interferon-stimulated transcriptionally independent isoform of ACE2 inhibits SARS-CoV-2 infection Olusegun O Onabajo, Megan Stanifer, A. Rouf Banday, Joselin Vargas, Wusheng Yan, Adeola Obajemu, et al. (+5)
193 [GO] 2023―Feb―07 SARS-CoV-2 infection drives endothelial dysfunction indirectly through hypoxia and increased pro-inflammatory cytokine production Taejoon Won, Megan K Wood, David M Hughes, Monica V Talor, Roger A Johns, Nisha A Gilotra, et al. (+3)
194 [GO] 2023―Feb―07 SARs-CoV-2 Infection Impacts the Function and Phenotype of Plasmacytoid Dendritic Cells Alicia L Codrington, Hannah Dewald, David Elson, Abby Chopoorian, Krzysztof Zembrziglel, Claire Park, et al. (+3)
195 [GO] 2023―Feb―07 Endogenous Type I interferon signaling plays a pivotal role in restricted SARS-CoV-2 infection in human ACE2 transgenic mice Kempaiah Rayavara Kempaiah, Aleksandra Drelich, Jason C Hsu, Vivian Tat, Chien-Te K Tseng
196 [GO] 2023―Feb―07 In Silico Assessment of SARS-CoV-2 Mutations with Relevancy to Prophylactic and Monoclonal-Based Treatment Strategies Lora Benoit, Deena Mikbel, Mario Vilela, Yusur Alsalihi, Dina Shakran, Edward Merino, Ali Mohseni
197 [GO] 2023―Feb―07 The SARS-CoV-2 proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms Christine Vazquez, Sydnie Swanson, Seble Negatu, Mark Dittmar, Holly Ramage, Sara Cherry, Kellie Jurado
198 [GO] 2023―Feb―07 SARS-CoV-2 related cytokines induce barrier function changes in human aortic endothelial cell monolayers: Implications for cytokine storm and vascular dysfunction. Carmen Elaine Campbell, William Boisvert
199 [GO] 2023―Feb―07 Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein Naveen Chandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, et al. (+11)
200 [GO] 2023―Feb―07 The comparison of two SARS-CoV-2 spike protein antigens in TLR-adjuvanted subunit vaccines. Haley A Partlow, Clara J. Davison, Stephanie K Lathrop, Jay T. Evans
201 [GO] 2023―Feb―07 HLA class II binding analysis for SARS-CoV-2 Spike through cell-surface MHC density assay Hiroko Miyadera, Nian Jiang
202 [GO] 2023―Feb―07 Co-immunization with adenosine deaminase rescues age-associated impairment of SARS-COV-2 synDNA vaccine-induced responses Ebony Nicole Gary, Jennifer Connors, Nicholas J. Tursi, Bryce Warner, Matthew Bell, Gina Cuismano, et al. (+9)
203 [GO] 2023―Feb―07 Pre-existing cellular immunity to SARS-CoV-2 through an immunodominant epitope Emma J Grant, Katie E Lineburg, Srividhya Swaminathan, Demetra S.M. Chatzileontiadou, Christopher Szeto, Hannah Sloane, et al. (+20)
204 [GO] 2023―Feb―07 Novel Multiplexed Assays for Antibody Isotypes against SARS-CoV-2 Using Flow Cytometry Kimvan T Tran, Julie Clor, Kamala Tyagarajan
205 [GO] 2023―Feb―07 Effect of SARS-CoV-2 vaccine on the breastmilk antibody response among lactating healthcare workers Lauren Stewart Stafford, Vivian Valcarce Luaces, Joseph Neu, Nicole Cacho, Leslie Parker, David Burchfield, et al. (+2)
206 [GO] 2023―Feb―07 SARS-CoV-2 vaccines induce potent immune responses in infant rhesus macaques Alan D Curtis, Carolina Garrido, Maria Dennis, Hongmei Gao, David Montefiori, Koen KA Van Rompay, et al. (+8)
207 [GO] 2023―Feb―07 Systematic examination of antigen-specific recall T cell responses to SARS-CoV-2 versus influenza virus reveals distinct inflammatory profile Jaclyn C Law, Wan Hon Koh, Patrick Budylowski, Jonah Lin, FengYun Yue, Kento T Abe, et al. (+10)
208 [GO] 2023―Feb―07 Rapid activation and expansion of peripheral gammadelta (γδ) T cells in SARS-CoV-2-infected nonhuman primates following aerosol exposure Alyssa Fears, Edith Walker, Nicole Chirichella, Nadia Slisarenko, Brandon Beddingfield, Nicholas J Maness, et al. (+2)
209 [GO] 2023―Feb―07 In vitro infection of human lung tissue with SARS-CoV-2: Heterogeneity in host defense and therapeutic response Matthew Schaller, Yamini Sharma, Zadia Dupee, Duy Nguyen, Juan Uruena, Ryan Smolchek, et al. (+3)
210 [GO] 2023―Feb―07 Differential use of complementarity-determining regions by synthetic nanobodies identifies multiple epitopes on receptor binding domain of SARS-CoV2 Javeed Ahmad Dhobi, Jiansheng Jiang, Lisa F Boyd, Kannan Natarajan, David H Margulies
211 [GO] 2023―Feb―07 Using standardized dry antibody panels for flow cytometry in the assessment of altered immune profiles in response to SARS-CoV2 infection Vashti Lacaille, Rita Bowers
212 [GO] 2023―Feb―07 SARS-CoV2 spike protein induces inflammatory molecules through TLR2 in macrophages and monocytes Hasan Zaki, Shahanshah Khan
213 [GO] 2023―Feb―07 Complex immunogenomic control of serum thyroid hormone levels in fetuses and piglets challenged with Porcine Reproductive and Respiratory Syndrome Virus Angelica G Van Goor, Alex Pasternak, Muhammed Walugembe, Glenn Hamonic, Jack Dekkers, John C. S. Harding, Joan K Lunney
214 [GO] 2023―Feb―07 Using practice tests as a vaccine to desensitize test anxiety in vulnerable students during pandemic induced lock-down. Aundriana Burtley, Uzoma Emeakoroha, Minh-Thu Nguyen, Jazmyne Durrah Simmons, Prabjyot Jhatu, Sonia Salamanca, Nadeem Fazal
215 [GO] 2023―Feb―07 The pandemic matrix gene is associated with increased pro-inflammatory immune responses during influenza virus infection Emily Fate Griffin, Shelly Curran, Mark Tompkins
216 [GO] 2023―Feb―07 Pan-academic in Pandemic! Remote learning goes viral, mostly out of control. Nadeem Fazal, Gulgaz Alakbarova
217 [GO] 2023―Jan―30 An Innate Checkpoint Determines Immune Dysregulation and Immunopathology during Pulmonary Murine Coronavirus Infection Sarah Grabherr, Alexandra Waltenspühl, Lorina Büchler, Mechthild Lütge, Hung-Wei Cheng, Sonja Caviezel-Firner, et al. (+3)
218 [GO] 2023―Jan―03 Meta-genomic detection of Candida spp. in the nasopharynx and upper airway of patients with severe COVID-19 Sarah C Glover, Vincent N Miao, Anna H Owings, Andrew W Navia, Ying Ting, Joshua D Bromley, et al. (+19)
219 [GO] 2023―Jan―03 Innate immune mechanisms underlying sex differences in COVID-19 Anshu Agrawal, Sudhanshu Agrawal, Jon Salazar, James Nguyen, Farah Rahmatpanah
220 [GO] 2023―Jan―03 Robust and prototypical immune responses towards COVID-19 BNT162b2 vaccines in Indigenous people Wuji Zhang, Lukasz Kedzierski, Brendon Y Chua, Adam K Wheatley, Louise Rowntree, Lilith Allen, et al. (+12)
221 [GO] 2023―Jan―03 Characterization of SARS-CoV-2-specific CD8+ T cells in COVID-19 convalescent, vaccinated, and individuals with respect to age Cecily Choy, Jian Lu, Jiangyuan Li, Humza Hemani, Joseph Chen, Ana Lustig, et al. (+13)
222 [GO] 2023―Jan―03 Sodium Pyruvate Inhalation for COVID-19 Long Hauler Symptoms - An Effective and Inexpensive Treatment Riley A Nadler
223 [GO] 2023―Jan―03 Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients Stefania Campana, Claudia De Pasquale, Giacomo Sidoti Migliore, Gaetana Pezzino, Riccardo Cavaliere, Emmanuele Venanzi Rullo, et al. (+7)
224 [GO] 2023―Jan―03 Immune determinants of cardiometabolic risk in pre-existing type-2 diabetes (T2D) severe COVID-19 patients Manuja Gayashan Bandara Gunasena, Yasasvi Wijewantha, Emily Bowman, Amendra Kumar, Krishanthi Weragalaarachchi, Jerra Furay, et al. (+8)
225 [GO] 2023―Jan―03 Exploration of shared antibody motifs in Kawasaki Disease (KD) and COVID-19 related Multisystem Inflammatory Syndrome of Childhood (MIS-C) Zehra Rahman, Mark Hicar
226 [GO] 2023―Jan―03 Bead-based Multiplex Assay Panels for Quantifying COVID-19 Vaccine-induced Serological Response, Neutralizing Antibodies and Cytokines Amy Zhao, Jessica Zhao, Edvelyn Webster, Cassandra Wheat, Binggang Sun, Jessie Ni
227 [GO] 2023―Jan―03 Comparison of the Immunogenicity of five COVID-19 vaccines in Sri Lanka J M K Chandima Jeewandara, Inoka Sepali Aberathna, Saubhagya Danasekara, Laksiri Gomes, Suranga Fernando, Dinuka Guruge, et al. (+19)
228 [GO] 2023―Jan―03 Changes of small non-coding RNAs by severe acute respiratory syndrome coronavirus 2 infection Wenzhe Wu, Ke Zhang, Eunjin Choi, Darby Buck, Binbin Wang, Awadalkareem Adam, et al. (+5)
229 [GO] 2023―Jan―03 Profiling MHC-I and MHC-II canonical and out-of-frame epitopes from SARS-CoV-2 and seasonal human coronavirus infected human cells Padma Pandurang Nanaware, Aniuska Becerra-Artiles, John Cruz, J. Mauricio Calvo-Calle, Muneeruddin Khaja, Scott A Shaffer, Lawrence J Stern
230 [GO] 2023―Jan―03 Evaluation of the long-term anti-Spike immune response following a novel coronavirus vaccine (CORVax): electroporation of SARS-CoV-2 Spike plasmid DNA plus IL12 plasmid DNA Shawn M Jensen, Michael Afentoulis, Keith Wegmann, David A Canton, Christopher G Twitty, Bernard A Fox
231 [GO] 2023―Jan―03 Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries Yi Luan, Qianying Yuan, Qijun Wang, Susan Compton, Dianqing Wu, Wenwen Tang
232 [GO] 2023―Jan―03 Pan-coronavirus neutralizing S2 human monoclonal antibodies and utility of direct respiratory administration as combination therapy with S1 antibodies against SARS-CoV-2 James Kobie, Jun-Gyu Park, Sanghita Sarkar, Madhubanti Basu, Andreas Loos, Jennifer Woo, et al. (+6)
233 [GO] 2023―Jan―03 Chemokine CXCL10’s role in the immune response to SARS-CoV-2 Hannah Ivester, Holly Morrison, Carla Finkielstein, Nisha Duggal, James Weger, Irving C Allen
234 [GO] 2023―Jan―03 Development of Quantitative Spike and Nucleocapsid Protein-Based Enzyme-Linked Immunosorbent Assays (ELISAs) for Measurement of Antibodies against SARS-CoV-2 Wen-Chieh Liao, Marissa Adame, Jess Webb, Dean Nguyen, Jessie Ni
235 [GO] 2023―Jan―03 Development of a Cell-based ELISA assay to assess memory IgG produced in vitro by B cells specific for spike protein of SARS-CoV-2 GIUSEPPE SCAPIGLIATI, Gianpaolo Zarletti, Massimo Tiberi, Veronica De Molfetta, Elisa Toppi, Paola Bossé
236 [GO] 2023―Jan―03 Mice infected with Mycobacterium tuberculosis are resistant to secondary infection with SARS-CoV-2 Oscar Rosas Mejia, Erin S. Gloag, Jianying Li, Marisa Ruane-Foster, Tiffany A Claeys, Daniela Farkas, et al. (+3)
237 [GO] 2023―Jan―03 Identifying highly conserved and immunogenic SARS-CoV-2 CD8+ T Cell Epitopes for Vaccine Design Jacqueline Carmona, Eric A Wilson, Padhmavathy Yuvaraj, Peaches R Ulrich, Abhishek Singharoy, Karen S Anderson
238 [GO] 2023―Jan―03 T Cell Responses In Children With Asthma Against SARS-CoV-2 Correlates To Asthmatic Outcomes Enwono Eyoh, Amelie Murrell, Derek Werthmann, Ivy Trinh, Addison Stone, Sruti Chandra, et al. (+9)
239 [GO] 2023―Jan―03 Assessing mucosal antibody responses to SARS-CoV-2 in humans and mice. Baweleta Isho, Kento Abe, Michelle Zuo, Alainna J Jamal, Eric Cao, Gary Chao, et al. (+6)
240 [GO] 2023―Jan―03 Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals Katelin Katsis, Mark B Leick, Rebecca C Larson, Trisha R Berger, Eva L Elder, Marcela V Maus, Kathleen M.E Gallagher
241 [GO] 2023―Jan―03 Differential serological immune imprinting following SARS-CoV-2 infection, vaccination, and breakthrough infection William Voss, Yimin Huang, Jeffrey Marchioni, Allison Seeger, Chelsea Paresi, Jessica Kain, et al. (+6)
242 [GO] 2023―Jan―03 Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection Salma Sheikh-Mohamed, Gary Chao, Baweleta Isho, Michelle Zuo, Carmit Cohen, Yaniv Lustig, et al. (+34)
243 [GO] 2023―Jan―03 Development of SARS-CoV-2 specific neutralizing recombinant monoclonal antibodies Pavitra Desai, Thangaraj Karuppuchamy, Nazia Syed, Sarath Unnikrishnan, Raghul Mathivanan, Nancy Priya, et al. (+4)
244 [GO] 2023―Jan―03 SARS-CoV-2 Spike395-404 is identified as a murine CD8+ T cell epitope in the receptor-binding domain of the SARS-CoV-2 spike protein Jihyun Yang, Eunjin Kim, Haryoung Poo
245 [GO] 2023―Jan―03 Cationic liposomes containing a TLR4 agonist promote the efficient development of cellular immunity against SARS-CoV-2 Spike protein in a subunit vaccine. Stephanie K Lathrop, Hardik H Amin, Clara J Davison, Haley A Partlow, Elizabeth K Lorentz, David J Burkhart, Jay T Evans
246 [GO] 2023―Jan―03 Persistence of immune memory to SARS-CoV-2 vaccine in lymphoid tissue Julia Davis-Porada, Ksenia Rybkina, Maya M.L. Poon, Daniel P Caron, Isaac J Jensen, Masaru Kubota, et al. (+8)
247 [GO] 2023―Jan―03 Longitudinal measurement of human immune responses to SARS-CoV-2 vaccines through serum immunoglobulins Kara Heatherton, Charleve Carey, William Hawkins, Stephanie Lacey
248 [GO] 2023―Jan―03 Vaccination of non-human primates with self-amplifying mRNA vaccines reveal two distinct immunotypes across major SARS-CoV-2 variants. Brian Martin Sullivan, Kathryn Hastie
249 [GO] 2023―Jan―03 Application of M-cell targeting ligand Co4B enhances Ag-specific mucosal and systemic immunity and protection against MERS-CoV infection after intranasal immunization Yong-Suk Jang, Ye Lin Yang, Ju Kim, Byeol-Hee Cho
250 [GO] 2023―Jan―03 Pandemic-induced pan-academic educational response in a minority university. Nadeem Fazal, Hafeez Faridi
251 [GO] 2023―Jan―03 Potential Clinical Applicability of The PHENotype SIMulator for In Silico Viral Co-Infection Studies in COVID-19 Naomi I. Maria, Rosaria Valentina Rapicavoli, Salvatore Alaimo, Evelyne Bischof, Alfredo Pulvirenti, Bud Mishra, et al. (+2)
252 [GO] 2023―Jan―03 Human KIR+ CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19 Jing Li, Maxim Zaslavsky, Yapeng Su, Jing Guo, Michael Sikora, Vincent van Unen, et al. (+29)
253 [GO] 2023―Jan―03 Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19 Jian Zheng, Lok-Yin Roy Wong, Kevin Wilhelmsen, Kun Li, Miguel E Ortiz, Nicholas J Schnicker, et al. (+17)
254 [GO] 2023―Jan―03 Intracellularly Delivered Nuclear Localization Sequence Attenuates The Severity Of COVID-19 By Inhibits Interaction Of Inflammatory Transcription Factors And Importins Dongho Kim, Gyunam Kim, Dasom Shin, Sanghyeon Yu, Misuk Baek, Jaewook Lee, et al. (+7)
255 [GO] 2023―Jan―03 Epigenetic immunophenotyping in monitoring of SARS-CoV2 vaccine response and COVID-19 disease course Janine Nadine Jung, Ulrich Hoffmueller, Bjoern Samans, Eva Raschke, Marta Rossello Chornet, Konstantin Schildknecht, et al. (+6)
256 [GO] 2023―Jan―03 Respiratory humoral and cellular immune responses following COVID-19 mRNA vaccination Jinyi Tang, Cong Zeng, Thomas M Cox, Chaofan Li, Young Min Son, In Su Cheon, et al. (+14)
257 [GO] 2023―Jan―03 COVID-19 patients are characterized by increased levels of immune cell membrane-bound and soluble CD48 Hadas Tamar Pahima, Ilan Zaffran, Amir Jarjoui, Efrat Orenbuch-Harroch, Pratibha Gaur, Ilaria Puxeddu, et al. (+4)
258 [GO] 2023―Jan―03 Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination Lauren Stewart Stafford, Vivian Valcarce, Josef Neu, Martina Mueller, Adetola Louis-Jacques, Valeria Vicuna, et al. (+10)
259 [GO] 2023―Jan―03 An inactivated SARS-CoV-2 vaccine causes enhanced type 2 inflammation in mice during coronavirus challenge. Jake Dillard, Sharon Taft-Benz, Audrey C. Knight, Elizabeth J. Anderson, Sanjay Sarkar, Jennifer F. Loome, et al. (+3)
260 [GO] 2023―Jan―03 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in a Bat Gastrointestinal Organoid Model Marziah Hashimi, Thomas Sebrell, Jodi Hedges, Deann Teresa Snyder, Katrina Lyon, Michelle D Cherne, et al. (+7)
261 [GO] 2023―Jan―03 Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant Setsuko Mise-Omata, Mari Ikeda, Masaru Takeshita, Yoshifumi Uwamino, Masatoshi Wakui, Tomoko Arai, et al. (+14)
262 [GO] 2023―Jan―03 SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation Bingyu Yan, Tilo Freiwald, Daniel Chauss, Luopin Wang, Erin West, Carmen Mirabelli, et al. (+24)
263 [GO] 2023―Jan―03 The SARS-CoV-2 encoded ORF8 protein Stimulates Human Monocytes to Produce Pro-Inflammatory Cytokines Gordon J Ruan, Xiaosheng Wu, Michelle K. Manske, Kevin E. Nowakowski, Jithma P. Abeykoon, Xingyi Tang, et al. (+8)
264 [GO] 2023―Jan―03 Maternal and Neonatal Antibody And T Cell Responses To SARS-CoV-2 Following Maternal Infection And/Or Vaccination Ivy Trinh, Enwono Eyoh, Amelie Murrell, Srushti Desai, Cody Lauritsen, Saraswatie Rambaran, et al. (+13)
265 [GO] 2023―Jan―03 Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation Jennifer R Habel, Brendon Y Chua, Lukasz Kedzierski, Kevin J Selva, Timon Damelang, Ebene R Haycroft, et al. (+40)
266 [GO] 2023―Jan―03 Circulating Monocytes Co-expressing Surface ACE2 and TMPRSS2 upon TLR4/7/8 Activation Are Susceptible to SARS-CoV-2 Infection Yi Yao, Kalpana Subedi, Jonathan Z. Sexton, Tingting Liu, Namir Khalasawi, Carla Pretto, et al. (+8)
267 [GO] 2023―Jan―03 The E3-ligase TRIM7 acts as an antiviral factor by ubiquitinating the SARS-CoV-2 membrane protein to limit apoptosis and virus replication Maria J Gonzalez Orozco, Adam Hage, Hongjie Xia, Matthew Huante, Sarah van Tol, Maria I Giraldo, et al. (+8)
268 [GO] 2023―Jan―03 Discovery of potently-neutralizing antibodies against SARS-CoV-2 using Barcode Enabled Antigen Mapping (BEAM) Michael JT Stubbington, Bruce Adams, Daniel Reyes, Ariel Royall, Maengseok Song, Sean Marrache, et al. (+8)
269 [GO] 2023―Jan―03 Comprehensive analysis of the durability and the quality of humoral and T cell responses in SARS-CoV-2 vaccinated and infected subjects. Kyra Woloszczuk, Jennifer R Connors, Gina Cusimano, Matthew Bell, Sara Furukawa, Nataliya Melnyk, et al. (+6)
270 [GO] 2023―Jan―03 Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination Jessica A. Breznik, Angela Huynh, Ali Zhang, Lucas Bilaver, Hina Bhakta, Hannah D. Stacey, et al. (+7)
271 [GO] 2023―Jan―03 Efficacy of pediatric SARS-CoV-2 vaccines against high-dose B.1.617.2 challenge one year after vaccination of infant rhesus macaques Emma C Milligan, Katherine Olstad, Patricio Cano, Jenny Munt, Lisa Lindesmith, Trevor Scobey, et al. (+13)
272 [GO] 2023―Jan―03 Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses Ramireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, Pratima Kumari, Luis E Munoz, Judy Oh, et al. (+15)
273 [GO] 2023―Jan―03 Phenotypical changes in peripheral NK cells and their impact on the clinical outcomes of patients with severe pandemic influenza A(H1N1) Jazmín Ariadna Ramírez-Noyola, Luis Alejandro Fernández-López, Lynette Miroslava Pacheco-Hernández, Sergio Ignacio-Cortés, Itzel Alejandra Gómez-García, Beatriz Garcia-Padrón, et al. (+3)
274 [GO] 2023―Jan―02 MicroRNA-155 enhances T-cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease Laura L. Dickey, Colleen Worne, Jessica Glover, Joshua Daugherty, Thomas Lane, Ryan M O’Connell
275 [GO] 2023―Jan―02 Phospholipase A2 group IID is indispensable for coronavirus-specific humoral immune memory in middle aged mice Jian Zheng, Stanley Perlman
276 [GO] 2023―Jan―02 CD40-targeted S1 subunit vaccine protects against MERS-CoV and S1-associated pulmonary immunopathology in transgenic human DPP4 mouse model Anwar M Hashem, Abdullah Algaissi, Anurodh Agrawal, Sawsan Al-amri, Abdulrahman Almasoud, Naif Alharbi, et al. (+3)
277 [GO] 2023―Jan―02 Analysis of SARS-CoV-2 pathogenicity in COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions Emiko Urano, Tomotaka Okamura, Yasuhiro Yasutomi
278 [GO] 2023―Jan―02 “The Great College Escape”-the most difficult choice offered to COVID-19 generation of global students. Nadeem Fazal, Nihat Cebiyev, Gulgaz Alakbarova, Ayshan Huseynbayli, Azer Garajayev, Arzu Safarova, et al. (+2)
279 [GO] 2023―Jan―02 Mapping the spatial biology of COVID-19 immunopathology in placenta tissues Ning Ma, Oliver Braubach, Patricia Zadorosnei Rebutini, Cleber Machado-Souza, Emanuele Therezinha Schueda Stonoga, Lucia de Noronha, et al. (+2)
280 [GO] 2023―Jan―02 ADAM-17 protease promotes inflammation and mortality while decreasing viral burden in a COVID-19 mouse model Jodi F Hedges, Deann T. Snyder, Amanda Robison, Heather Walk, Karlin Havlak, Kelly Shepardson, et al. (+4)
281 [GO] 2023―Jan―02 Polyfunctionality of T cell immunity in pre-immune and naïve individuals after COVID-19 mRNA vaccination Vanessa S Moraes, Ted M Ross
282 [GO] 2023―Jan―02 Effect of methotrexate on response to Covid-19 mRNA vaccines in patients with Autoimmune Inflammatory Rheumatic Diseases: a longitudinal study Violeta Rus, Vinh Nguyen, Mallory Shriver, Mary Degrezia, Eaman Alhassan, Marcella Passetti, et al. (+2)
283 [GO] 2023―Jan―02 Molecular mechanisms of dexamethasone-mediated modulation of inflammatory and interferon responses in severe COVID-19 patients. Ameet A Chimote, Abdulaziz Alshwimi, Martina Chirra, Vaibhavkumar S Gawali, Kristin M Hudock, Margaret V Powers-Fletcher, Laura Conforti
284 [GO] 2023―Jan―02 Persistence of SARS-CoV-2 in long COVID-19 patients Denise Goh, Jeffrey Chun Tatt Lim, Sonia Bilbao Fernandez, Justina Nadia Lee, Craig Ryan Joseph, Sílvia Guerrero, et al. (+3)
285 [GO] 2023―Jan―02 Epigenetic regulation of inflammatory genes involving histone methylation is associated with hyperimmune response in COVID-19 patients Xiaoming Yang, Xiaoming C Yang, Xiaoming Yang, Xiaoming Yang, Julian Julian, Timothy Schnell, et al. (+4)
286 [GO] 2023―Jan―02 Nasopharyngeal inflammatory lymphocytes perturbation in COVID-19 severity prediction Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Jin Zhang, Ramya Ramankutty Nair, Jun Dai, et al. (+5)
287 [GO] 2023―Jan―02 Circulating extracellular vesicles from patients with severe COVID-19 upregulate Cathepsin B and activate STAT3 in normal human mesangial cells Sarah C Glover, Yogesh Scindia, Lauren P Liu, Neha Dhaliwal, Haley Williams, Yilianys Pride, et al. (+3)
288 [GO] 2023―Jan―02 Immunogenicity and efficacy of a multiple antigen-presenting system (MAPS™) COVID-19 vaccine in Non-human Primates Gilles Besin, brian Cieslewicz, Daniel Makrinos, Renuka Haridas, Heidi Burke, Taylor Stevenson, Richard Malley
289 [GO] 2023―Jan―02 Severe acute respiratory syndrome coronavirus 2 vaccination induces short-term polyclonal antibody response against seasonal endemic coronaviruses Bindu Adhikari, Eugene M. Oltz, Richard J. Gumina, Linda J. Saif, Anastasia N. Vlasova
290 [GO] 2023―Jan―02 Identification of conserved coronavirus epitopes targeted by antibodies after SARS-CoV-2 infection or vaccination Todd Bradley, Eric Geanes, Cas LeMaster, Elizabeth R Fraley, Santosh Khanal, Rebecca McLennan, et al. (+2)
291 [GO] 2023―Jan―02 Repurposed antibiotic and antiviral drugs inhibit the immune evasive endoribonuclease of SARS-CoV-2 and restrict coronavirus infection in vitro Troy Alexander von Beck, Luis Mena Hernandez, Hongyi Zhou, Jeffrey Skolnick, Joshy Jacob
292 [GO] 2023―Jan―02 Correction: Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries
293 [GO] 2023―Jan―02 Evaluation of cellular immune responses induced in mice by alphavirus replicon particle vaccines for SARS-CoV (B190) Elizabeth A Reap, Pamela K Norberg, Aubrey D Watson, Chad Cecil, Jordan Wagner, Kurt I Kamrud, Jonathan Smith
294 [GO] 2023―Jan―02 Evaluation of the immunogenicity of an alphavirus replicon particle vaccine expressing the SARS-CoV spike (S) glycoprotein in non-human primates (B191) Elizabeth A Reap, Aubrey D Watson, Pamela K Norberg, Chad Cecil, Ronna E Dornsife, Kurt I Kamrud, Jonathan Smith
295 [GO] 2023―Jan―02 In vitro assessment of neutrophil response to proteins and antibodies of SARS-CoV-2 Nathalie Bonatti Franco Almeida, Kayla Marie Fantone, Demba Sarr, Rafaella Fortini Queiroz Grenfell, Balazs Rada
296 [GO] 2023―Jan―02 Clonal structure and epitope specificity of Ad5-nCoV vaccine-induced T cell response to SARS-CoV-2 Savely Sheetikov, Alexandra A Khmelevskaya, Ksenia V Zornikova, Ivan V. Zvyagin, Alina S. Shomuradova, Andrei Afanasiev, et al. (+2)
297 [GO] 2023―Jan―02 C-type lectin receptor MGL-1 in SARS-CoV-2 disease pathogenesis Matthew B Huante, Maria J Gonzalez Orozco, Kubra F. Naqvi, Yazmin Berenice Martinez-Martinez, Vineet Menachery, Janice J Endsley, et al. (+3)
298 [GO] 2023―Jan―02 SARS-CoV-2 epitope-specific CD8+ clonotypes persist 8 month post-infection despite reduced clonality. Ksenia V Zornikova, Alexandra Khmelevskaya, Savely Sheetikov, Olga V. Shcherbakova, Dmitry Kirukhin, Aleksei Titov, et al. (+2)
299 [GO] 2023―Jan―02 Prediction of immunodominant CD4+ SARS-CoV-2 epitopes with TCR repertoire sequencing data Mikhail Pogorelyy, Anastasia Minervina, Elisa Rosati, Philip Mudd, Ali Ellebedy, Paul G Thomas
300 [GO] 2023―Jan―02 Children with Multi-System Inflammatory Syndrome (MIS-C) develop functionally competent T cell memory against SARS-CoV-2 following recovery Ksenia Rybkina, Marissa C Bradley, Joseph N Bell, Wenzhao Meng, Michael P DiLorenzo, Brett R Anderson, et al. (+4)
301 [GO] 2023―Jan―02 Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice Jacob S Yount, Ashley Zani, Adam D. Kenney
302 [GO] 2023―Jan―02 SARS-CoV-2 induced oxidative stress promotes HMGB1 secretion to induce inflammation Yashoda Madaiah Hosakote, Kempaiah Rayavara, Levine B Corri, Susan McLellan, Scott C Weaver, Ashok Chopra, Chein-Te K Tseng
303 [GO] 2023―Jan―02 Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 Infection Stephen T Yeung, Thomas A Premeaux, Toshiro Niki, Satish K Pillai, Kamal M Khanna, Lishomwa C Ndhlovu
304 [GO] 2023―Jan―02 Endogenous interferon-lambda signaling restricts virus replication and disease severity in a murine model of SARS-CoV-2 infection Abigail Solstad, Adam D. Kenney, Ashley Zani, Jacob S. Yount, Emily A. Hemann
305 [GO] 2023―Jan―02 Differences between autoantibodies induced by SARS-CoV-2 infection and Pfizer-BioNTech SARS-CoV-2 vaccination Eric S Geanes, Todd Bradley
306 [GO] 2023―Jan―02 Spike BATTLE: Simultaneous evaluation of antigen-specific B and T lymphocytes following natural SARS-CoV-2 infection and subsequent mRNA vaccination Krista L Newell, Mitchell J Waldran, Stephen J Thomas, Timothy P Endy, Adam T Waickman
307 [GO] 2023―Jan―02 Epitope-specific T cell response to SARS-CoV-2 infection and vaccination Anastasia Minervina, Mikhail Pogorelyy, Allison M Kirk, Ching-Heng Chou, E Kaitlynn Allen, Jeremy Chase Crawford, et al. (+2)
308 [GO] 2023―Jan―02 Baseline NK cell frequencies are greater in individuals with asymptomatic SARS-CoV-2 infection compared to those that develop symptomatic illness Elizabeth Graydon, Alyssa Lindrose, Stephen Anderson, Allison Malloy, Stephen Lizewski, Rhonda Lizewski, et al. (+5)
309 [GO] 2023―Jan―02 SARS-CoV-2 infection reduces the frequencies of angiogenic CD4 and CD8 T cells (Tang) Maryam AbdusSamad, Tong Li, Joseph Timpone, Jai Kumar, Princy Kumar, Ryan C Hunt, Marta Catalfamo
310 [GO] 2023―Jan―02 Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes Murugesan Rajaram, Qian Wu, Naresh Kumar, Noushin Salijoughian, Ashley Zani, Ashley Patton, et al. (+3)
311 [GO] 2023―Jan―02 Sequence similarity between SARS-CoV-2 Nucleocapsid and CNS proteins provides mechanistic insight into viral neuropathogenesis following infection Camille Lake, Joseph Breen
312 [GO] 2023―Jan―02 QuickSwitch™: a validated platform for both screening MHC binding SARS-CoV-2 peptides and making SARS-CoV-2 specific MHC class I and II tetramers. Yuri O Poluektov, Marc Delcommenne, Pirouz M Daftarian, Marybeth George
313 [GO] 2023―Jan―02 Antibody-dependent enhancement of SARS-CoV-2 spike binding to human ACE2 receptor by virus neutralizing antibodies Nicholas J Magazine, Yongjun Guan, Lei Yu, Mariano Carossino, Tianyi Zhang, Michael C McGee, Weishan Huang
314 [GO] 2023―Jan―02 Exposure to SARS-CoV-2 spike protein induces antigen specific IgE and basophil activation Tianyi Zhang, Nicholas Magazine, Michael Conrad McGee, Weishan Huang
315 [GO] 2023―Jan―02 A Longitudinal Study of Humoral Immune Responses to SARS-CoV-2 Spike Proteins in Gamma-Interferon-inducible Lysosomal Thiol Reductase Deficient Mice Xiao He, Li Guo, Hu Dai, Peter E Jensen
316 [GO] 2023―Jan―02 Antibody ‘Hotspots’ induce antibody-dependent cell-mediated cytotoxicity against SARS-CoV-2 spike-expressing lung fibroblasts Kayla Holder, Keeley Hatfield, Danielle Ings, Katie Fifield, Debbie Harnum, Michael Grant
317 [GO] 2023―Jan―02 Peripheral co-immunization with CCL27 drives robust mucosal responses to SARS-CoV-2 synDNA antigens and provides heterologous protection against Delta variant challenge Ebony Nicole Gary, Nicholas J Tursi, Bryce Warner, Elizabeth Parzych, Ali Ali, Darwyn Kobasa, et al. (+3)
318 [GO] 2023―Jan―02 TLR2 senses spike protein of SARS-CoV-2 to trigger inflammation Hasan Zaki, Shahanshah Khan
319 [GO] 2023―Jan―02 B cell receptor repertoire dynamics and convergent evolution following SARS-CoV-2 vaccination Elizabeth Ross Fraley, Santosh Khanal, Cas LeMaster, Stephen Pierce, Tomi Pastinen, Todd Bradley
320 [GO] 2023―Jan―02 SARS-CoV-2 vaccination induces T cell memory responses able to cross-recognize ongoing SARS-CoV-2 variants including omicron. Alba Grifoni, Alison Tarke, Jennifer Dan, Camila Coelho, Zeli Zhang, Daniela Weiskopf, et al. (+3)
321 [GO] 2023―Jan―02 Comprehensive comparison of adaptive immune responses to inactivated SARS-CoV-2 vaccine between young and old Chanchan Xiao, Zhiyao Ren, Bei Zhang, Lipeng Mao, Pengcheng Wang, Xiaofeng Liang, et al. (+2)
322 [GO] 2023―Jan―02 Hybrid immunity and vaccine breakthrough lead to robust humoral response and antibodies that effectively neutralize SARS-CoV-2 variants Timothy A Bates, Savannah K McBride, Hans C Leier, Zoe L Lyski, William B Messer, Marcel E Curlin, Fikadu G. Tafesse
323 [GO] 2023―Jan―02 Immune responses to SARS-Cov-2 variants in adult and elderly mRNA vaccine recipients Mladen Jergovic, Jennifer Uhrlaub, Makiko Watanabe, Christopher P Coplen, Janko Nikolich-Zugich
324 [GO] 2023―Jan―02 Computational fingerprinting of immune-mediated pressure on SARS-CoV-2 viral evolution reveals preliminary evidence for immune-evasion Tomer Hertz, Liel Cohen-Lavi, Sinai Sachren, Eilay Koren, Anat Burkovitz
325 [GO] 2023―Jan―02 Development of a cell free virus free beads-based SARS-Cov-2 virus neutralization assay Xiaohong Hou, Emily Sims, Wenjing Pan, Brittany Brown, Miranda Steele, Stephanie Song, Jian Han
326 [GO] 2023―Jan―02 Role(s) of Pulmonary Macrophage and Dendritic Cells in SARS-CoV-Induced Host Inflammatory Responses: An in vitro Model. (43.39) Tomoki Yoshikawa, Nan Wang, Clarence J Peters, Chien-Te K Tseng
327 [GO] 2023―Jan―02 Human Defensin-5 (HD-5) and HD-6 mRNA Produced by Intestinal Crypt Paneth Cells are Decreased in Fecal Samples of Patients Positive for SARS-CoV2 Lisa K Ryan, Tanya O. Robinson, Erika H. Figgins, Uyen ‘Emily’ Do, Kenneth J. Wilson, Sarah C. Glover, Gill Diamond
328 [GO] 2023―Jan―02 Durability of B and T cell responses against a spike protein of SARS-CoV2 elicited by mRNA vaccines Lauren Taylor Hamilton, Yoshinobu Koguchi, Tanisha Christie, Takashi Shimada, Noriko Iwamoto, Bernie Fox, et al. (+2)
329 [GO] 2023―Jan―02 OX40 boosts and sustains humoral and cellular immune responses to SARS-CoV2 spike protein and RNA vaccinations Rebekka A Duhen, Michael Beymer, Shawn Jensen, Srinivas Abbina, Suraj Abraham, Anitha Thomas, et al. (+3)
330 [GO] 2023―Jan―02 Developing MHV-1 infection as an animal model for Severe Acute Respiratory Syndrome (SARS) (43.30) Aaruni Khanolkar, Lecia Pewe, Delia Tifrea, Stanley Perlman, John T. Harty
331 [GO] 2023―Jan―02 Do immune genes influence which pigs will have persistent Porcine Reproductive and Respiratory Syndrome virus (PRRSV) infections? (45.5) Joan K. Lunney, Raymond Rowland, Eric Nelson, Ramon Molina, Joseph Hermann, Daniel Kuhar, et al. (+3)
332 [GO] 2023―Jan―02 Cell death in pandemic and seasonal influenza viruses (VIR2P.1027) Boris Hartmann, Randy Albrecht, Nada Marjanovic, Soanli Patil, Miguel Fribourg, Stuart Sealfon
333 [GO] 2023―Jan―02 The role of T cell leptin signaling in 2009 pandemic H1N1 influenza infection mortality in obese mice (VIR2P.1013) J. Milner, Matthew Meyers, Patricia Sheridan, Peter Mancuso, Melinda Beck
334 [GO] 2023―Jan―02 Improvement of the aging-related reduced efficacy of the H1N1 pandemic influenza vaccine by the complex of poly-γ-glutamic acid and alum Jaemoo Kim, Yang Jihyun, Poo Haryoung
335 [GO] 2023―Jan―02 Female minority students-plight of staying alive in education during an unending pandemic! Nadeem Fazal, Minh-Thu Nguyen, Jazmyne Durrah Simmons, Sandra Olk, Prabjyot Jhatu
336 [GO] 2023―Jan―02 Is it not over yet? - pandemic-induced ongoing burn out continues for students in Azerbaijan. Nadeem Fazal, Nihat Cebiyev, Gulgaz Alakbarova, Ayshan Huseynbayli, Azer Garajayev, Arzu Safarova Safarova
337 [GO] 2023―Jan―01 IFN-γ expression by regulatory T cells in the CNS of mice persistently infected with neurotropic coronavirus (137.27) Jingxian Zhao, Stanley Perlman
338 [GO] 2023―Jan―01 The Role of IL-10 in Mice Infected with Neurotropic Murine Coronavirus (43.14) Kathryn A Trandem, Stanley Perlman
339 [GO] 2023―Jan―01 Rat coronavirus infection of alveolar type I cells causes neutrophil recruitment followed by resolution of infection (45.28) Tanya A. Miura, Joel Funk, Kathryn V. Holmes, Robert J. Mason
340 [GO] 2023―Jan―01 Selection of CTL Escape Mutants in Mice Infected with a Neurotropic Coronavirus: Quantitative Estimate of TCR Diversity in the Infected Central Nervous System Lecia Pewe, Stephen B. Heard, Conni Bergmann, Morris O. Dailey, Stanley Perlman
341 [GO] 2023―Jan―01 T-cell responses in mouse-adapted SARS-CoV infected mice (52.22) Jincun Zhao, Stanley Perlman
342 [GO] 2023―Jan―01 Protective and Pathologic roles of the Immune Response to Mouse Hepatitis Virus-1 (MHV-1): Implications for Severe Acute Respiratory Syndrome (128.8) Aaruni Khanolkar, Stacey M Hartwig, Lecia L Pewe, Steven M Varga, John T Harty
343 [GO] 2023―Jan―01 The role of different virus-specific effector memory T-cell subsets in response to influenza A/H3N2 and pandemic A/H1N1 strains in older compared to young adults (92.2) Xin Zhou, Janet McElhaney
344 [GO] 2023―Jan―01 Fatal outcome of pandemic H1N1 2009 influenza infection is associated with neutrophil and macrophage lung infiltration but not enhanced viral burden in pregnant mice. (111.3) Glendie Marcelin, Jerry Aldridge, Adrianus Boon, Susu Duan, Jerold Rehg, Richard Webby
345 [GO] 2023―Jan―01 Regulation of proinflammatory cytokine Interleukin-6 (IL-6) induction by NF-kappaB signaling in pandemic H1N1 influenza A virus-infected human bronchial epithelial cells (45.29) Zheng Xing, Wei Gao, Bingqian Qu, Xue Li, Yu Jin, Ku Yang, Carol Cardona
346 [GO] 2023―Jan―01 Cytokine expression pattern differences between conserved versus non-conserved influenza pandemic H1N1-specific CD4 T cells (49.15) Jason Weaver, Nan Deng, Courtney Bishop, Tim Mosmann
347 [GO] 2023―Jan―01 Positioning of the HA Globular Head within the TLR5 Agonist, Flagellin, Modulates the Immunogenicity and Reactogenicity of a Novel-H1 Pandemic Influenza Vaccine (136.13) Scott Umlauf, John Gathuru, Rodney Bell, Fu Hou, Lucia Reiserova, Langzhou Song, et al. (+3)
348 [GO] 2023―Jan―01 Adjuvanting influenza vaccines for enhanced immunity to seasonal or pandemic influenza virus. (75.9) Jeffery Fairman, Tim Carroll, Feng Liu, Kathy Hancock, Jacqueline Katz, Xiuhua Lu, et al. (+2)
349 [GO] 2023―Jan―01 Development of a rapid diagnostic kit for antigen and antibody of Middle East respiratory syndrome coronavirus Eun-Young Lee, Hae Li Ko, Seo-Yeon Jung, Jae-Hwan Nam
350 [GO] 2023―Jan―01 Early CD4 T cell help fails to rescue CD8 T cell-mediated control of neurotropic coronavirus infection (154.8) Timothy Phares, Stephen Stohlman, Cornelia Bergmann
351 [GO] 2023―Jan―01 Spike nanoparticle and recombinant adenovirus 5 vaccines induce specific antibodies against the Middle East respiratory syndrome coronavirus (MERS-CoV) Hyo-Jung Park, Eun-Young Lee, SeoYeon Jung, Hae Li Ko, Sang-Myeong Lee, Jae-Hwan Nam
352 [GO] 2023―Jan―01 Host Transcriptome Studies in Response to Feline Coronavirus Reveal Differences in Macrophages vs CRFK Yvonne Drechsler, Elton JR Vasconcelos, Pedro PVP Diniz
353 [GO] 2023―Jan―01 Age-related dysregulation in the lipidome compromises the immune response to the severe acute respiratory coronavirus (VIR5P.1140) RAHUL VIJAY, Michael Gelb, Makoto Murakami, Stanley Perlman
354 [GO] 2023―Jan―01 Anti-spike IgG exacerbates lung injury by skewing monocyte-macrophage responses during SARS-CoV infection Li Liu, Haibo Wang, Qiang Wei, Hangying Tang, Kenji Nishiura, Hauyee Kwok, et al. (+4)
355 [GO] 2023―Jan―01 Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice Rudragouda Channappanavar, Anthony Fehr, Rahul Vijay, Zhao Jincun, David K Meyerholz, Stanley Perlman
356 [GO] 2023―Jan―01 Intranasal immunization of porcine reproductive and respiratory syndrome virus entrapped biodegradable PLGA- nanoparticles elicits virus specific cross-protective immune responses in pigs (161.21) Varun Dwivedi, Cordelia Manickam, Basavaraj Binjawadagi, Ruthi Patterson, Katie Dodson, Renukaradhya Gourapura
357 [GO] 2023―Jan―01 Analysis of the expressed porcine antibody repertoire in porcine and reproductive and respiratory syndrome virus infected pigs (P6077) John Schwartz, Michael Murtaugh
358 [GO] 2023―Jan―01 Porcine messenger RNA and microRNA pathway analysis of Porcine Reproductive and Respiratory Syndrome Virus infection Laura C Miller, Damarius Fleming
359 [GO] 2023―Jan―01 Understanding fetal immune responses to congenital porcine reproductive and respiratory syndrome virus infection Laura C Venner, Linjun Hong, Andrea Ladinig, John C S Harding, Joan Lunney
360 [GO] 2023―Jan―01 Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibody production to major envelope protein peptides (49.22) Juan Li, Michael Murtaugh
361 [GO] 2023―Jan―01 Porcine reproductive and respiratory syndrome virus non-structural protein Nsp2TF down-regulates Swine Leukocyte Antigen class I (SLA class I) expression Qian Cao, Sakthivel Subramaniam, Dianjun Cao, Xiang-Jin Meng
362 [GO] 2023―Jan―01 Comparative analysis of signature genes in Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)-infected porcine monocyte-derived dendritic cells at differential activation statuses. Laura C Miller, Yongming Sang, Darrell O Bayles, Frank Blecha
363 [GO] 2023―Jan―01 The pig heavy and light chain immunoglobulin repertoires provide insights into the adaptive immune response against porcine reproductive and respiratory syndrome virus (PRRSV). (160.4) John Schwartz, Michael Murtaugh, Juan Abrahante
364 [GO] 2023―Jan―01 Infection with Porcine Reproductive and Respiratory Syndrome virus (PRRSv) impacts immune cell metabolism without evidence of cell-mediated immune response. Crystal L Loving, Zahra F Olson, Wes P Schweer, Nicholas K Gabler
365 [GO] 2023―Jan―01 Vaccine Induced Protection of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection in swine (113.3) Khushboo Hemnani, Jessie Trujillo, Tanja Opriessnig, Robert Messel, Gregory Tobin, Peter Nara
366 [GO] 2023―Jan―01 Probing host immune response to porcine reproductive and respiratory syndrome virus (PRRSV) infection using 3′RNAseq and NanoString arrays Kristen Walker, Linjun Hong, James M. Reecy, Elyn Fritz-Waters, Qian Dong, Robert R. R. Rowland, et al. (+5)
367 [GO] 2023―Jan―01 Transcriptomic analysis reveals the potential of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus to modulate immune system activation related to host-pathogen and damage associated signaling in infected porcine monocytes. Laura C Miller, Damarius Fleming, Xiangdong Li, Darrell Bayles, Frank Blecha, Yongming Sang
368 [GO] 2023―Jan―01 PLGA nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine coadministered intranasally with a potent adjuvant elicits cross-protective immunity in the pig respiratory system (VAC7P.981) Basavaraj Binjawadagi, Varun Dwivedi, Cordelia Manickam, Kang Ouyang, Jordi Torrelles, Renukaradhya Gourapura
369 [GO] 2023―Jan―01 Natural killer T cell adjuvanted inactivated swine influenza virus vaccine enhanced the viral load and suppressed the host immune response to pandemic 2009 H1N1 virus in pigs (P6093) Renukaradhya Gourapura, Cordelia Manickam, Varun Dwivedi, Kang Ouyang, Basavaraj Binjawadagi, Kara Henn, et al. (+3)
370 [GO] 2023―Jan―01 Longitudinal analyses of human sera reveal expansions of antibody titers specific to previously-encountered pandemic and seasonal influenza viruses (P6366) Matthew Miller, Thomas Gardner, Florian Krammer, Lauren Aguado, Domenico Tortorella, Christopher Basler, Peter Palese
371 [GO] 2023―Jan―01 The role of mannose binding lectin (MBL) in co-infection of pandemic H1N1 and Streptococcus pneumoniae (168.14) Man To Ling, Yan Han, Wen Wei Tu, Pak Leung Ho, Yu Lung Lau
372 [GO] 2023―Jan―01 Comparing NKT cell therapy to oseltamivir phosphate (Tamiflu®) for controlling pandemic H1N1 influenza Bianca Libanori Artiaga, Guan Yang, Julia Loeb, Jürgen Richt, Jeffrey Abbott, John Lednicky, John Driver
373 [GO] 2023―Jan―01 The Complex of Poly-γ-Glutamic Acid and Alum Induces Cross-Protective Immunity of Pandemic H1N1 Influenza Vaccine Quyen Thi Nguyen, Chaewon Kwak, Jaemoo Kim, Jihyun Yang, Haryoung Poo
374 [GO] 2023―Jan―01 An investigation for IL-6 responses in patients with pandemic influenza A (H1N1) infection (168.20) Emin Bagriacik, Nurhan Albayrak, Basak Altas, Mustafa Ertek
375 [GO] 2023―Jan―01 Protection by a broadly neutralizing monoclonal antibody to pandemic Influenza requires selective Fc receptor engagement (P4216) David DiLillo, Gene Tan, Peter Palese, Jeffrey Ravetch
376 [GO] 2023―Jan―01 Poly gamma glutamic acid-chitosan nanogel dramatically enhances the protective efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine in mice and ferrets (P4281) Haryoung Poo
377 [GO] 2023―Jan―01 Suppression of dendritic cell necroptosis by pandemic influenza virus Boris M. Hartmann, Randy A Albrecht, Nada Marjanovic, Stuart C Sealfon
378 [GO] 2023―Jan―01 Age-associated cross-reactive antibody-dependent cellular cytotoxicity to 2009 H1N1 influenza prior to the pandemic (P6160) Sinthujan Jegaskanda, Karen Laurie, Thakshila Amarasena, Wendy Winnall, Marit Kramski, Robert De Rose, et al. (+4)
379 [GO] 2023―Jan―01 Contribution of 2009 pandemic swine-origin influenza virus gene segments to virulence and immunity (67.23) John Stambas, Justin Evans, Deborah Middleton, Sue Lowther, Rachel Robinson, Jessica Haining, et al. (+6)
380 [GO] 2022―Dec―31 Intraepithelial leukocytes contain a unique subpopulation of NK-like cytotoxic cells active in the defense of gut epithelium to enteric murine coronavirus. P S Carman, P B Ernst, K L Rosenthal, D A Clark, A D Befus, J Bienenstock
381 [GO] 2022―Dec―31 In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. S A Stohlman, G K Matsushima, N Casteel, L P Weiner
382 [GO] 2022―Dec―31 Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J L VanCott, T A Brim, J K Lunney, L J Saif
383 [GO] 2022―Dec―31 Isotype-specific antibody-secreting cells to transmissible gastroenteritis virus and porcine respiratory coronavirus in gut- and bronchus-associated lymphoid tissues of suckling pigs. J L VanCott, T A Brim, R A Simkins, L J Saif
384 [GO] 2022―Dec―31 Antiidiotypic vaccination against murine coronavirus infection. A Lamarre, J Lecomte, P J Talbot
385 [GO] 2022―Dec―31 Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells. A Suzumura, E Lavi, S Bhat, D Murasko, S R Weiss, D H Silberberg
386 [GO] 2022―Dec―31 Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy. J J Hooks, C Percopo, Y Wang, B Detrick
387 [GO] 2022―Dec―31 Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells. H Körner, A Schliephake, J Winter, F Zimprich, H Lassmann, J Sedgwick, et al. (+2)
388 [GO] 2022―Dec―30 Protection from lethal coronavirus infection by immunoglobulin fragments. A Lamarre, P J Talbot
389 [GO] 2022―Dec―30 Antigenic Relationships Among the Coronaviruses of Man and Between Human and Animal Coronaviruses Kenneth McIntosh, Albert Z. Kapikian, Kathleen A. Hardison, Janet W. Hartley, Robert M. Chanock
390 [GO] 2022―Oct―20 Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 Infection Anurag Adhikari, Arunasingam Abayasingam, Chaturaka Rodrigo, David Agapiou, Elvis Pandzic, Nicholas A. Brasher, et al. (+18)
391 [GO] 2022―Oct―20 Coronavirus Lung Infection Impairs Host Immunity against Secondary Bacterial Infection by Promoting Lysosomal Dysfunction Xiaohua Peng, Jooyoung Kim, Gayatri Gupta, Karen Agaronyan, Madeleine C. Mankowski, Asawari Korde, et al. (+16)
392 [GO] 2022―Oct―20 Immune Responses to SARS-CoV-2 in Pregnancy: Implications for the Health of the Next Generation Lydia L. Shook, Lindsay T. Fourman, Andrea G. Edlow
393 [GO] 2022―Jul―14 Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity Malena M. Pérez, Vinícius E. Pimentel, Carlos A. Fuzo, Pedro V. da Silva-Neto, Diana M. Toro, Thais F. C. Fraga-Silva, et al. (+27)
394 [GO] 2022―Jul―13 Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved Mladen Jergović, Christopher P. Coplen, Jennifer L. Uhrlaub, Shawn C. Beitel, Jefferey L. Burgess, Karen Lutrick, et al. (+3)
395 [GO] 2022―Jul―12 Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1 Gina M. Cusimano, Ebony N. Gary, Matthew R. Bell, Bryce M. Warner, Jennifer Connors, Nicholas J. Tursi, et al. (+13)
396 [GO] 2022―Apr―29 Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil Hyon-Xhi Tan, Kathleen M. Wragg, Hannah G. Kelly, Robyn Esterbauer, Benjamin J. Dixon, Jillian S. Y. Lau, et al. (+7)
397 [GO] 2022―Apr―04 Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients Xiaoming Yang, Alex C. Rutkovsky, Juhua Zhou, Yin Zhong, Julian Reese, Timothy Schnell, et al. (+4)
398 [GO] 2022―Apr―04 Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women Nardhy Gomez-Lopez, Roberto Romero, Li Tao, Meyer Gershater, Yaozhu Leng, Chengrui Zou, et al. (+13)
399 [GO] 2022―Apr―01 Virus-Specific Regulatory T Cells Persist as Memory in a Neurotropic Coronavirus Infection Alan Sariol, Jingxian Zhao, Juan E. Abrahante, Stanley Perlman
400 [GO] 2022―Mar―23 SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients Bo Zhai, Karen Clarke, David L. Bauer, Krissy K. Moehling Geffel, Saran Kupul, Lucas J. Schratz, et al. (+5)
401 [GO] 2022―Mar―14 Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients Yevgeniy Yuzefpolskiy, Peter Morawski, Mitch Fahning, Cate Speake, Sandra Lord, Anu Chaudhary, et al. (+7)
402 [GO] 2022―Feb―28 Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG Veronica P. Costantini, Kenny Nguyen, Zoe Lyski, Shannon Novosad, Ana C. Bardossy, Amanda K. Lyons, et al. (+9)
403 [GO] 2022―Feb―04 Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly Lil Meyer-Arndt, Tatjana Schwarz, Lucie Loyal, Larissa Henze, Beate Kruse, Manuela Dingeldey, et al. (+12)
404 [GO] 2022―Jan―31 Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine Alexey A. Komissarov, Inna V. Dolzhikova, Grigory A. Efimov, Denis Y. Logunov, Olga Mityaeva, Ivan A. Molodtsov, et al. (+6)
405 [GO] 2022―Jan―17 The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population Michael K. Tu, Samantha H. Chiang, Richard A. Bender, David T. W. Wong, Charles M. Strom
406 [GO] 2022―Jan―07 SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy Chao Sui, Tongyang Xiao, Shengyuan Zhang, Hongxiang Zeng, Yi Zheng, Bingyu Liu, et al. (+3)
407 [GO] 2022―Jan―05 Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease Taru S. Dutt, Stephanie M. LaVergne, Tracy L. Webb, Bridget A. Baxter, Sophia Stromberg, Kim McFann, et al. (+8)
408 [GO] 2021―Dec―13 Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset Jaclyn C. Law, Melanie Girard, Gary Y. C. Chao, Lesley A. Ward, Baweleta Isho, Bhavisha Rathod, et al. (+10)
409 [GO] 2021―Nov―24 ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling Beibei Wu, Arunachalam Ramaiah, Gustavo Garcia, Spyridon Hasiakos, Vaithilingaraja Arumugaswami, Sonal Srikanth
410 [GO] 2021―Oct―13 Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Kalipada Pahan
411 [GO] 2021―Oct―04 Cutting Edge: Lung-Resident T Cells Elicited by SARS-CoV-2 Do Not Mediate Protection Against Secondary Infection Lydia M. Roberts, Forrest Jessop, Tara D. Wehrly, Catharine M. Bosio
412 [GO] 2021―Oct―04 SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals Yanling Liu, Patrick Budylowski, Shilan Dong, Zhijie Li, Sofiya Goroshko, Leslie Y. T. Leung, et al. (+8)
413 [GO] 2021―Aug―27 Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19 Qianting Yang, Yanling Wen, Furong Qi, Xiang Gao, Weixin Chen, Gang Xu, et al. (+8)
414 [GO] 2021―Aug―20 SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis Inês Alves, Manuel Machado Vicente, Joana Gaifem, Ângela Fernandes, Ana Mendes Dias, Cláudia Sousa Rodrigues, et al. (+6)
415 [GO] 2021―Aug―13 Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence Tongcui Ma, Heeju Ryu, Matthew McGregor, Benjamin Babcock, Jason Neidleman, Guorui Xie, et al. (+8)
416 [GO] 2021―Aug―04 Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19 Daniel Reynolds, Cristina Vazquez Guillamet, Aaron Day, Nicholas Borcherding, Rodrigo Vazquez Guillamet, José Alberto Choreño-Parra, et al. (+6)
417 [GO] 2021―Jul―26 The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated Shima Shahbaz, Lai Xu, Wendy Sligl, Mohammed Osman, Najmeh Bozorgmehr, Siavash Mashhouri, et al. (+4)
418 [GO] 2021―Jul―23 SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain Rafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, Laura Pérez-Alós, Cecilie Bo Hansen, Laust Bruun Johnsen, et al. (+10)
419 [GO] 2021―Jun―30 Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity William E. Matchett, Vineet Joag, J. Michael Stolley, Frances K. Shepherd, Clare F. Quarnstrom, Clayton K. Mickelson, et al. (+14)
420 [GO] 2021―Jun―28 SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19 José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós, Charbel Maroun-Eid, Verónica Terrón-Arcos, Karla Montalbán-Hernández, et al. (+14)
421 [GO] 2021―Jun―28 A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs Deli Huang, Jenny Tuyet Tran, Linghang Peng, Linlin Yang, Raymond T. Suhandynata, Melissa A. Hoffman, et al. (+13)
422 [GO] 2021―Jun―02 Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation Gautam Anand, Alexandra M. Perry, Celeste L. Cummings, Emma Raymond, Regina A. Clemens, Ashley L. Steed
423 [GO] 2021―May―28 Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19 Kenneth B. Hoehn, Palaniappan Ramanathan, Avraham Unterman, Tomokazu S. Sumida, Hiromitsu Asashima, David A. Hafler, et al. (+5)
424 [GO] 2021―May―28 Metabolic Defects of Peripheral T Cells in COVID-19 Patients Xiaoju Liu, Juanjuan Zhao, Haiyan Wang, Wan Wang, Xu Su, Xuejiao Liao, et al. (+3)
425 [GO] 2021―May―21 Influenza Virus and SARS-CoV-2 Vaccines Adam M. Sandor, Michael S. Sturdivant, Jenny P. Y. Ting
426 [GO] 2021―May―12 Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors Bernd Jahrsdörfer, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Carolin Ludwig, Tatjana Schwarz, et al. (+9)
427 [GO] 2021―May―12 Identification of T Cell Epitopes in the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 in Rhesus Macaques Xiaojuan Liu, Yuzhong Li, Hongjian Xiao, Yanwei Bi, Yue Gong, Zhengrong R. Hu, et al. (+6)
428 [GO] 2021―May―10 Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein Jake C. Harbour, Zoe L. Lyski, John B. Schell, Archana Thomas, William B. Messer, Mark K. Slifka, Jeffrey C. Nolz
429 [GO] 2021―May―10 Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination Bennett J. Davenport, Thomas E. Morrison, Ross M. Kedl, Jared Klarquist
430 [GO] 2021―May―05 Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain Grace Mantus, Lindsay E. Nyhoff, Robert C. Kauffman, Venkata Viswanadh Edara, Lilin Lai, Katharine Floyd, et al. (+11)
431 [GO] 2021―May―03 Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients Hidetsugu Fujigaki, Masato Inaba, Michiko Osawa, Saya Moriyama, Yoshimasa Takahashi, Tadaki Suzuki, et al. (+7)
432 [GO] 2021―Apr―28 Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines Swayam Prakash, Ruchi Srivastava, Pierre-Gregoire Coulon, Nisha R. Dhanushkodi, Aziz A. Chentoufi, Delia F. Tifrea, et al. (+9)
433 [GO] 2021―Apr―12 Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients Qihong Yan, Pingchao Li, Xianmiao Ye, Xiaohan Huang, Bo Feng, Tianxing Ji, et al. (+12)
434 [GO] 2021―Mar―29 Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease Philip S. Crooke, John T. Tossberg, Krislyn P. Porter, Thomas M. Aune
435 [GO] 2021―Feb―12 The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression Wei Huang, Mei Li, Guangwei Luo, Xiaojie Wu, Bintao Su, Lan Zhao, et al. (+6)
436 [GO] 2021―Feb―08 T Cell Phenotyping in Individuals Hospitalized with COVID-19 Janine Rupp, Barbara Dreo, Katharina Gütl, Johannes Fessler, Adrian Moser, Bernd Haditsch, et al. (+5)
437 [GO] 2021―Feb―05 IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study Marco Franzetti, Andrea Forastieri, Noemi Borsa, Alessandro Pandolfo, Chiara Molteni, Luca Borghesi, et al. (+15)
438 [GO] 2021―Jan―13 Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses Vineet Joag, Sathi Wijeyesinghe, J. Michael Stolley, Clare F. Quarnstrom, Thamotharampillai Dileepan, Andrew G. Soerens, et al. (+20)
439 [GO] 2020―Dec―30 Coronavirus Receptors as Immune Modulators Charan Kumar V. Devarakonda, Emily Meredith, Mallika Ghosh, Linda H. Shapiro
440 [GO] 2020―Dec―09 Repurposed Tocilizumab in Patients with Severe COVID-19 Jianbo Tian, Ming Zhang, Meng Jin, Fengqin Zhang, Qian Chu, Xiaoyang Wang, et al. (+12)
441 [GO] 2020―Dec―09 A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients Henning Zelba, David Worbs, Johannes Harter, Natalia Pieper, Christina Kyzirakos-Feger, Simone Kayser, et al. (+4)
442 [GO] 2020―Dec―04 Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators Benjamin Schwarz, Lokesh Sharma, Lydia Roberts, Xiaohua Peng, Santos Bermejo, Ian Leighton, et al. (+6)
443 [GO] 2020―Nov―18 SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals Cecilie Bo Hansen, Ida Jarlhelt, Laura Pérez-Alós, Lone Hummelshøj Landsy, Mette Loftager, Anne Rosbjerg, et al. (+9)
444 [GO] 2020―Nov―18 Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile Jaclyn C. Law, Wan Hon Koh, Patrick Budylowski, Jonah Lin, FengYun Yue, Kento T. Abe, et al. (+10)
445 [GO] 2020―Nov―05 SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals Pedro Martínez-Fleta, Arantzazu Alfranca, Isidoro González-Álvaro, Jose M. Casasnovas, Daniel Fernández-Soto, Gloria Esteso, et al. (+11)
446 [GO] 2020―Oct―30 Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19 Erik H. Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen, Simone Kruithof, Pleuni Ooijevaar-de Heer, Gerard van Mierlo, et al. (+21)
447 [GO] 2020―Sep―25 Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19 Merve Kalkan Yazıcı, Meliha Meric Koç, Nesibe Selma Çetin, Elif Karaaslan, Gulay Okay, Bulent Durdu, et al. (+2)
448 [GO] 2020―Sep―21 Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm Alexandre E. Nowill, Pedro O. de Campos-Lima
449 [GO] 2020―Sep―04 Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns Nicole Baumgarth, Janko Nikolich-Žugich, F. Eun-Hyung Lee, Deepta Bhattacharya
450 [GO] 2020―Sep―02 Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients Renata Varnaitė, Marina García, Hedvig Glans, Kimia T. Maleki, John Tyler Sandberg, Janne Tynell, et al. (+10)
451 [GO] 2020―Aug―21 Neonatal and Children’s Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy Shokrollah Elahi
452 [GO] 2020―Aug―03 Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε Lok-Yin Roy Wong, Zi-Wei Ye, Pak-Yin Lui, Xuyang Zheng, Shuofeng Yuan, Lin Zhu, et al. (+9)
453 [GO] 2020―Jul―22 COVID-19: Complement, Coagulation, and Collateral Damage Martin W. Lo, Claudia Kemper, Trent M. Woodruff
454 [GO] 2020―Jul―17 SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production Rafael Franco, Rafael Rivas-Santisteban, Joan Serrano-Marín, Ana I. Rodríguez-Pérez, José L. Labandeira-García, Gemma Navarro
455 [GO] 2020―Jul―10 A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections Marika Orlov, Pandora L. Wander, Eric D. Morrell, Carmen Mikacenic, Mark M. Wurfel
456 [GO] 2020―Jun―26 A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection Wafaa B. Alsoussi, Jackson S. Turner, James B. Case, Haiyan Zhao, Aaron J. Schmitz, Julian Q. Zhou, et al. (+16)
457 [GO] 2020―Jun―08 Early Insights into Immune Responses during COVID-19 Ashley L. St. John, Abhay P. S. Rathore
458 [GO] 2020―Jun―03 Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19 Judy Chen, William J. Kelley, Daniel R. Goldstein
459 [GO] 2020―Jun―03 Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19 Jeremy K. Y. Yap, Miyu Moriyama, Akiko Iwasaki
460 [GO] 2020―May―18 COVID-19 as an Acute Inflammatory Disease Rose H. Manjili, Melika Zarei, Mehran Habibi, Masoud H. Manjili
 [1] 

460 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.016 sec